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Chapter 1: General Introduction 
  
 2 
Introduction 
Immigrants to the U.S. arrive relatively free of endemic chronic diseases, but their health 
eventually deteriorates over time to match that of their American counterparts. This 
“healthy immigrant effect” (Kennedy et al., 2006) unfolds at different rates and with 
different severities, as some groups develop disproportionately higher risks of disease 
than others (Antecol and Bedard, 2006). Given that immigrants are the fastest growing 
group in the U.S. and are projected to make up 20% of the population by 2050 (Passel 
and Cohn, 2008), prevention of obesity and related diseases in this population will have 
large implications on public health and the U.S. economic health burden. Behavioral and 
social risk factors (Bates et al., 2008; Cairney and Ostbye, 1999; Goel et al., 2004; 
Kaplan et al., 2004; Lauderdale and Rathouz, 2000; McTigue et al., 2002; Walker et al., 
2008), such as sedentary lifestyles, western diet, and low socioeconomic status, have 
been well-described and are important considerations for preventing and managing 
obesity. Unfortunately, the etiology of obesity is further complicated by host-specific 
factors such as genetics and more recently, the gut microbiome (Ley et al., 2005, 2006; 
Schwiertz et al., 2010; Turnbaugh and Gordon, 2009; Turnbaugh et al., 2006). The gut 
microbiome plays a critical role in host metabolism and because it is largely shaped by 
the external environment, varies based on an individual’s geographical origin 
(Yatsunenko et al., 2012). New and severe environmental exposures can lead to 
disruptions in gut homoestasis (David et al., 2014; Dethlefsen and Relman, 2011; 
Turnbaugh et al., 2009a), which have been associated with a variety of diseases, 
including obesity. Thus, there is a critical need to determine how the gut microbiome 
adapts to the permanent and often severe environmental changes characteristic of 
immigration between under-developed and western countries. In the absence of such 
knowledge, the strategies used to combat obesity and related diseases among U.S. 
immigrant and minority populations will only be partially effective. 
 
  
 3 
Background and Literature Review 
The U.S. is home to a growing immigrant population whose health is declining over time 
An estimated 40 million immigrants (foreign-born individuals) reside in the U.S. (13% of 
the population as of 2010), representing the fastest growing segment of the population 
(Goel et al., 2004). Immigrants are projected to make up 20% of the population by 2050 
(Passel and Cohn, 2008). Minnesota is home to the highest number of refugees per capita 
in the U.S., and is currently expecting the largest wave of refugees in the last decade 
(Koumpilova, 2015). The Hmong, a minority ethnic group from China and Southeast 
Asia, make up the largest refugee group in Minnesota (22,033 total refugees as of 2014) 
(Minnesota Department of Health), and also form the largest centralized Hmong 
community in the U.S. (70,000 total individuals) (Pfeifer and Thao, 2013). Karen 
refugees from Burma (Myanmar) have been arriving in large numbers in recent years 
(Minnesota Department of Health), also from a similar region in Asia. Past work reveals 
that length of residence in the U.S. increases the risk of obesity, with some groups 
experiencing up to a four-fold increase in obesity risk after 15 years (Bates et al., 2008; 
Cairney and Ostbye, 1999; Goel et al., 2004; Kaplan et al., 2004; Lauderdale and 
Rathouz, 2000; Walker et al., 2008). This “healthy immigrant effect” has been well-
documented in western countries (Antecol and Bedard, 2006), yet occurs at varying 
degrees among different groups (e.g. Mexican-born females are at highest risk of 
developing obesity (Barcenas et al., 2007)). In Minnesota, increasing levels of dietary 
acculturation has been correlated with increasing BMI among Hmong (Mulasi-Pokhriyal 
et al., 2012; Smith and Franzen-Castle, 2012), and the prevalence of overweight and 
obesity is highest among Hmong compared to other Asian ethnic groups (Arcan et al., 
2014; Franzen and Smith, 2009; Himes et al., 1992; Mulasi-Pokhriyal et al., 2012). 
Limited data exists for the more recently arrived Karen, yet these trends suggest that this 
group will soon be at risk. With the recent crises in the middle east, the U.S. is expected 
to increase the number of accepted refugees by 25% over the next two years (Morello, 
2016). There is a need to gain a basic understanding of how these migrations impact 
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human health in order to ensure that these populations transition to life in the U.S. as 
seamlessly as possible. 
 
Central role of the human microbiome in human health 
The human microbiome, the trillions of microorganisms that live inside and on our 
bodies, is an important contributor to human health. These microbial communities aid in 
immune system development, protection against pathogenic infections, and host 
metabolism. Furthermore, distinct gut microbiome compositions have been associated 
with various disease states, such as Crohn’s disease (Gevers et al., 2014), cancers (Wang 
et al., 2012), diabetes (Qin et al., 2012), allergy and asthma (Abrahamsson et al., 2012; 
Atarashi et al., 2013; Bisgaard et al., 2011), and obesity (Ley et al., 2006; Turnbaugh and 
Gordon, 2009; Turnbaugh et al., 2006). There is enormous potential for the gut 
microbiome to serve as a biomarker for the diagnostics and prevention of diseases, and to 
also serve as a target for prebiotic and probiotic therapeutics in combating disease. 
 
Western diet induces pronounced deleterious effects on the gut microbiome 
With a critical role in host metabolism, the gut microbiome composition is heavily 
influenced by an individual’s long-term diet (Hildebrandt et al., 2009; Wu et al., 2011), 
yet can also quickly respond to drastic dietary changes (David et al., 2014; Turnbaugh et 
al., 2009a). African Americans and rural South Africans who exchanged diets for two 
weeks also exchanged their respective cancer risks, as indicated by mucosal biomarkers 
and microbiome shifts (O’Keefe et al., 2015). Aside from being animal-based, high-fat, 
and low-fiber, the western diet harbors other food components that have recently been 
under scrutiny, such as artificial sweeteners inducing glucose intolerance (Suez et al., 
2014) and dietary emulsifiers inducing metabolic syndrome (Chassaing et al., 2015). 
Although diet has been shown to be a major determinant of gut microbiome composition, 
it also exhibits resilience in some states, and therefore may show limited response to diet 
alone (Smith et al., 2013). Perhaps more importantly for immigrants and their future 
generations, diet modifications are unable to recover microbes that have been lost over 
several generations (Sonnenburg et al., 2016). 
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Loss of co-evolved microbes contributes to rise in chronic diseases 
Although our study captures diet acculturation as a western exposure driving risk of 
obesity, we also explore evidence of how westernization contributes to the “disappearing 
microbiota” hypothesis (Blaser and Falkow, 2009), which suggests that the loss of 
indigenous organisms that have coevolved with humans may be contributing to the rise in 
chronic diseases. This hypothesis is supported by several studies, which found that 
greater diversity and novel taxa are present in non-western versus western human gut 
microbiomes (Clemente et al., 2015; Obregon-Tito et al., 2015; Yatsunenko et al., 2012). 
Furthermore, there may be a strong health-promoting relationship between a specific set 
of microbes and the respective population that harbors it. Kodaman et al. found that two 
clusters of Helicobacter pylori strains were found among African and Amerindian 
populations, and were benign when strain ancestry and human ancestry matched, but 
deleterious for gastric cancer risk when an individual with African ancestry harbored an 
Amerindian H. pylori strain and vice-versa (Kodaman et al., 2014). 
 
Other western exposures contribute to disruption of gut homeostasis 
Exposure to broad-spectrum antibiotics, commonly used in western medicine, can lead to 
imbalances in the gut microbiome. Evidence for antibiotics-induced obesity is primarily 
characterized by shifts in functional capability, or more specifically, long-lasting 
metabolic shifts that result from incomplete recovery back to the normal trajectory. 
Recent work found that mice given sub-therapeutic levels of antibiotics after weaning 
exhibited increased adiposity, large taxonomic changes in their gut microbiomes, and 
increased levels of short-chain fatty acids (SFCAs) as well as counts of bacterial genes 
involved in SFCA metabolism (Cho et al., 2012a). These mice also had lower caloric 
output in their faecal pellets despite dietary intake similar to controls, suggesting their gut 
microbiota developed the ability to extract increased energy from indigestible 
components (Cho et al., 2012a). Furthermore, use of multiple courses of broad-spectrum 
antibiotics can perturb the gut microbiome such that complete recovery is unattainable 
(Dethlefsen and Relman, 2011). 
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Gut microbiome mediates obesity 
Obesity risk can be attributed partially to host genetics, but recently has been found to be 
considerably associated with differences in the gut microbiome (Ley et al., 2005, 2006; 
Schwiertz et al., 2010; Turnbaugh and Gordon, 2009; Turnbaugh et al., 2006). The gut 
microbiome is much more dynamic than the human genome; it exhibits substantial inter-
individual variability (unrelated individuals share only 30% of their gut microbiomes as 
opposed to 99.9% of their genomes), and intra-individual variability (an individual’s gut 
microbiome changes over days, weeks, and months (Bäckhed et al., 2005; Faith et al., 
2013)). Gut microbiomes transplanted from lean or obese individuals into mice directly 
induces weight loss or gain, respectively, implicating the gut microbiome as a causal 
factor in obesity (Ridaura et al., 2013; Smith et al., 2013; Turnbaugh et al., 2006). 
Additionally, weight loss is dependent on the initial gut microbiome composition, and 
stability of an individual’s weight is directly associated with the stability of his or her gut 
microbiome (Faith et al., 2013; Santacruz et al., 2009). 
 
Effects of fiber on gut health and obesity 
Although the gut microbiome may serve as an important biomarker for obesity, it also 
holds enormous potential for modifying host metabolism. Consumption of dietary fiber is 
important for promoting gut microbial diversity; it is fermented into beneficial short-
chain fatty acids, and as a result is important for combating various gut conditions 
associated with obesity, such as increased gut permeability and low-grade inflammation 
(Cani et al., 2009a; Maachi et al., 2004). Studies show that gut microbiota fermentation 
of dietary fiber promotes satiety (Cani et al., 2009b; Parnell and Reimer, 2012) and is 
involved in a variety of signaling pathways that maintain glucose and energy homeostasis 
(De Vadder et al., 2014). It is well established among epidemiological studies that 
consumption of dietary fiber is important for weight loss (Howarth et al., 2001; Liu et al., 
2003; Slavin, 2005), and that non-Western populations with fiber-rich diets have lower 
incidences of obesity (Cerqueira et al., 1979; Lindeberg and Lundh, 1993). 
Characterizing the effect of dietary fiber consumption in preserving or restoring native 
gut microbiomes among immigrant populations has significant implications for both the 
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prevention and treatment of obesity, and subsequent development of obesity-related 
diseases, in these at-risk populations. 
 
Study objectives and overall approach 
The long-term goal of the research contained in this thesis is to identify key factors that 
support a healthy transition to life in the U.S., so that improved strategies can prevent the 
development of endemic chronic diseases among new Americans. The main objective is 
to understand the role of the gut microbiome in mediating increased risk of obesity within 
Hmong and Karen refugees and immigrants as they adapt to western diet and 
environment. We hypothesize that immigration and subsequent exposure to 
westernization induces dramatic and permanent shifts in the gut microbiome directly 
associated with increased risk of obesity. The rationale for the main human study 
described in this thesis is that its successful completion would provide a strong 
conceptual framework for the implementation of a comprehensive dietary or probiotic 
intervention targeted at multiple groups.  
 
Specific Aim 1: Determine changes in the gut microbiome attributed to the length of 
residence in the U.S. and obesity risk.   
Hypothesis: Obesity risk is characterized by low diversity, overgrowth of pathogens, or 
increased energy extraction in the gut microbiome, and becomes more pronounced with 
U.S. residence. 
• Analyze gut microbiomes from a cross-section of lean and overweight/obese 
Hmong and Karen women prior to immigration, newly arrived in the U.S., resided 
longer-term in the U.S., and who were born in the U.S. 
• Use taxonomic marker gene amplicon sequencing and deep shotgun 
metagenomics to measure shifts in functional and taxonomic compositions, and 
taxonomic biodiversity 
• Correlate microbiome features with anthropometric measurements used to assess 
obesity risk and length of residence in the U.S., while statistically controlling for 
intake of a subset of dietary nutrients, migration history, and antibiotic exposures 
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Specific Aim 2: Characterize gut microbiome recovery immediately after immigration.   
Hypothesis: Immigration induces compositional and functional shifts observable within 
the first 6 months in the U.S. 
• Characterize gut microbiome adaptation to residency in the U.S. at 1-month 
intervals within the same individual, and statistically controlling for intake of a 
subset of dietary nutrients, migration history, antibiotic exposures, and 
anthropometric measurements 
• Use taxonomic marker gene amplicon sequencing and deep shotgun 
metagenomics to measure shifts in functional, taxonomic, taxonomic biodiversity, 
and rate of change in the gut microbiome 
 
Specific Aim 3: Identify dietary components with utility of preserving the native gut 
microbiome.   
Hypothesis: Dietary fiber promotes maintenance of the native gut microbiome and 
protects against obesity risk.  
• Transplant gut microbiomes from pre-immigration and second-generation 
immigrant individuals into gnotobiotic mice, and apply a series of dietary 
interventions including varying diversity and concentration of fibers to determine 
their ability to preserve or deplete the native gut microbiome. 
• Dietary intervention groups will be compared to assess differences in body 
composition, metabolic markers, and metagenomic compositions to infer 
mechanistic connections between the microbiome, diet, and metabolism. 
 
Community-based research 
Community involvement was a critical aspect of the human study described in Chapter 4 
as the research team is a composed of community and academic members. In addition to 
the co-Principal Investigators and co-investigators listed above, our U.S. research team is 
composed of Hmong and Karen community researchers, all of whom have been trained 
on CBPAR methods and are current leaders in their communities. Their main roles have 
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been to consult with the development of recruitment materials, translate recruitment 
materials, contribute to the study design, promote and recruit for the study, prepare gut 
health educational materials, and deliver the dissemination event. To enhance community 
input, we have formed a community advisory board (CAB) with community leaders, 
community health professionals, and at-large community members from both Hmong and 
Karen communities. Early in the project, the community-academic research team held 
discussions with the CAB to discuss knowledge and awareness of the project topic, 
identify optimal recruitment strategies, review the study design and recruitment materials, 
and pilot the consent forms and surveys. The information from these discussions directly 
informed our study design, methodology, and dissemination strategies. Two additional 
advisory board meetings were held throughout the study period: (1) to check the progress 
of recruitment, troubleshoot, and improve the process, and (2) to prepare for the 
dissemination of results at the end of the study.  
 
Dissertation Organization 
This dissertation is organized as three manuscripts which have either been published or 
are being prepared for submission. It contains a general introduction, a description of the 
overall study objective and approach, one perspective paper, one technical paper, and one 
research paper, and an overall conclusions chapter. Note that these distinct article formats 
differ in organization; the technical paper does not contain a discussion section, and the 
research paper, which is formatted for submission to a specific journal, has a results 
section that embodies limited methods, results, and some discussion. Figures and 
references for all chapters can be found at the end of this paper.  
 
Chapter 2 is a perspective paper that combines both an in-depth literature review with a 
proposed model of studying antibiotic-induced dysbiosis in the infant gut microbiome. 
This chapter lays the groundwork for how critical the gut microbiome is in immune 
system development and for maintaining long-term health, and discusses an important 
Western-associated factor, antibiotics, in the context of gut health. Chapter 3 is a 
technical note describing a machine learning repository of curated microbiome datasets 
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for the computational community. This chapter is the result of important validation work 
done with published datasets, which was necessary for estimating sample sizes, selecting 
computational and statistical methods, and validating bioinformatics tools used for the 
human study found in Chapter 4. Chapter 4 forms the focal point of this dissertation, and 
describes human gut microbiome changes in immigrants and refugees in the United 
States (U.S.). Chapter 5 provides a conclusion section that discusses the findings, broader 
impact, and future work resulting from this thesis. 
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Chapter 2: Antibiotics, pediatric dysbiosis, and disease 
 
 
 
 
 
Pajau Vangay, Tonya Ward, Jeffrey Gerber, and Dan Knights 
 
 
*A version of this chapter has been published in:  
Cell Host Microbe. 2015 May 13;17(5):553-64.   
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This chapter discusses an exposure commonly associated with developed countries: 
antibiotics. Here, we describe the important relationship between the gut microbiome and 
the immune system, and discuss the ramifications of overuse of antibiotics and its 
deleterious effects on gut microbiome development. 
 
Introduction 
Epidemiological studies have identified links between antibiotic usage in early infancy 
and diseases such as obesity, diabetes, and asthma. Longitudinal studies of antibiotic 
usage have demonstrated profound short- and long-term effects of antibiotics on the 
diversity and composition of the gut microbiota. While a large and growing number of 
studies implicate dysbiosis in numerous diseases (Biedermann and Rogler, 2015), there 
are currently few studies directly linking antibiotics, pediatric dysbiosis, and the later 
development of disease. The vast majority of antibiotic use occurs in the outpatient 
setting, where up to a third of prescriptions are unnecessary. Furthermore, even when 
antibiotics are indicated, the use of broad-spectrum antibiotics has increased dramatically 
over the past two decades, which could influence the structure and function of the 
developing microbiome more dramatically than targeted antibiotics. Understanding the 
short- and long-term effects of early life antibiotic use on the diversity and composition 
of the gut microbiota is critical in identifying the risks associated with these emerging 
prescription trends. 
 
Overprescription trends 
Antibiotics are by far the most common prescription drugs given to children (Chai et al., 
2012). In 2010, children received 74.5 million outpatient antibiotic prescriptions—one 
for every child in the US—accounting for one fourth of all medications for children 
(Hicks et al., 2013). Numerous studies have demonstrated that antibiotics are often 
prescribed unnecessarily (Gonzales et al., 2001; McCaig et al., 2003; Nash et al., 2002), 
with some estimates as high as 50% (Kronman et al., 2014). Nearly 30% of children 
receive an antibiotic prescription during an outpatient primary care visit (McCaig et al., 
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2003), most often inappropriately, for viral upper respiratory tract infections (Gonzales et 
al., 2001; Nash et al., 2002; Nyquist et al., 1998). Overuse of broad-spectrum antibiotics 
for conditions responsive to narrow-spectrum agents has been dramatically increasing 
(Hersh et al., 2013). Even after adjusting for differences in patient age, comorbidities, and 
sociodemographic factors, children with the same infections can receive vastly different 
rates of antibiotic prescriptions depending upon the practice or clinician visited (Fierro et 
al., 2014; Gerber et al., 2014). This phenomenon also seems to be universal: per capita 
antibiotic prescribing rates vary widely across US states (Hicks et al., 2013) and 
European countries (Goossens et al., 2005) , without reasonable cause for geographic 
differences in bacterial infection rates. These prescribing patterns suggest that (1) 
antibiotics are often overprescribed and (2) benchmarking data available in the form of 
clinical practices and geographical regions can be used to prescribe lower rates of 
antibiotics to help guide more judicious prescribing elsewhere. 
 
Additional harmful effects of antibiotic exposure 
In addition to the gut microbiome-mediated effects discussed below, inappropriate 
prescribing of antibiotics can lead to both drug-related adverse effects and the promotion 
of antibiotic resistance. More than 140,000 emergency department (ED) visits occur 
annually in the US for antimicrobial-related adverse effects, comprising almost 20% of 
all ED visits for drug-related adverse effects (Shehab et al., 2008). In addition to this 
direct patient harm, antibiotic use has been associated with the emergence of 
antimicrobial resistance, identified by the World Health Organization (WHO) as “one of 
the three greatest threats to human health.” Infections with resistant bacteria increase 
morbidity and mortality, and greatly increase the cost of medical care; the Institute of 
Medicine estimated that, in 2010, roughly $20 billion was spent on the treatment of 
antibiotic-resistant infections. Knowledge of these facts, however, has done little to curb 
antimicrobial use. Improving our awareness of the long-term implications of both 
necessary and unnecessary antibiotic exposure is important to better inform the 
risk/benefit ratio for antibiotic prescribing and to improve child health. 
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Normal host-microbiome development 
 
Gastrointestinal development 
Gastrointestinal (GI) development occurs throughout embryonic life, and its basic 
structure is first formed by the end of the first gestational trimester (Montgomery et al., 
1999). Tight junctions are present by 10 weeks of gestation and intestinal villi are formed 
by weeks 12-19 (Maheshwari and Zemlin, 2009; Montgomery et al., 1999; Polak-
Charcon et al., 1980). Postnatally, an abrupt shift in exposure from amniotic fluid to first 
foods occurs in the GI tract. This induces many changes along the GI tract, including a 
change in pH of the stomach. For example, some reports state the pH of the stomach is 
initially in the range of 6 – 8 (Avery et al., 1966), likely due to buffering by the amniotic 
fluid, which decreases to that of an adult (pH 1.5 - 2.5) within the first hours following 
birth (Kelly et al., 1993; Lebenthal and Lebenthal, 1999; Ménard, 2004). However, due to 
the consumption of milk, and its buffering capabilities, the pH of the infant stomach often 
returns to a circum neutral level of 7-7.6 (Hibberd et al., 1982). The higher pH of the 
stomach early in life has a meaningful impact, including a higher absorption rate of 
nutrients and a diminished digestive capacity compared to later in life, which may 
support transit of ingested bacteria to colonize the lower GI tract. Throughout postnatal 
development, the infant GI tract also increases in size in both length and in diameter, and 
loses most of its early-stage porosity within days post birth due to milk-borne growth 
factors and hormones that stimulate growth and development (Cummins and Thompson, 
2002). 
 
Development of the GI-associated lymphoid tissue (GALT), including mesenteric lymph 
nodes, Peyer’s patches, and lymphocytes in the lamina propria, is complete in full-term 
infants at birth (Forchielli and Walker, 2005). For example, goblet cells, responsible for 
mucin production, are functional by 12 weeks of gestation (Montgomery et al., 1999), as 
are Paneth cells, which can secrete defensins and lysozymes by gestational weeks 13 and 
20, respectively (Louis and Lin, 2009; Maheshwari and Zemlin, 2009; Rumbo and 
Schiffrin, 2005). Although full-term infants are born with fully developed digestive 
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tracts, exogenous stimulation through exposure to dietary antigens, hormones, growth 
factors, and bacteria is required to elicit proper function throughout life (Forchielli and 
Walker, 2005). 
 
Microbiome development 
Although the gastrointestinal tract of a healthy infant is generally considered to be sterile 
before birth, recent work suggests that initial colonization may take place in-utero 
(Aagaard et al., 2014; Funkhouser and Bordenstein, 2013; Matamoros et al., 2013). Hours 
after birth, microorganisms from the mother’s vaginal, fecal, and/or skin microbiome and 
the environment are important colonizers of the infant gut (Penders et al., 2006), with 
actual contributions depending on mode of delivery. Several other factors including 
prematurity, infant diet (breast milk or formula), hygiene, and use of antibiotics will 
ultimately impact the composition of the infant gut microbiome. Despite a seemingly 
chaotic colonization, with large swings in composition over time, gut microbiome 
development is governed by Darwinian dynamics: microbes best adapted for the 
changing conditions of the gut will be most likely to survive. We can see this clearly 
throughout the first few weeks of life, as the colonization of facultative aerobes reduces 
the availability of oxygen, which then permit the growth of strict anaerobes 
(Bezirtzoglou, 1997). As illustrated in Figure 2.1, compositional changes in response to 
diet and host development ocurr throughout the first year of life. In the United States, the 
infant gut is initially colonized with Proteobacteria and Firmicutes, followed by a gradual 
increase in Actinobacteria (potentially due to the introduction of breastmilk (Favier et al., 
2003; Sela et al., 2008; Yoshioka et al., 1983)). By six months of age, Bacteroidetes 
dominate while Proteobacteria and Actinobacteria gradually decline, which may be 
attributed to the abundance of carbohydrates in solid foods that coincides with weaning 
(Koenig et al., 2011; Vaishampayan et al., 2010). By the end of the first year of life, the 
infant gut is dominated by bacterial phyla Bacteroides and Firmicutes (Figure 2.1). The 
healthy infant gut continues with dramatic compositional changes throughout the first 
two years of life before becoming indistinguishable from an adult gut microbiome at age 
three (Yatsunenko et al., 2012). 
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Important host-microbiome interactions 
Maturation of the intestinal immune system is contingent on parallel development of the 
gut microbiome (Figure 2.1). Germ-free animals have been found with significant 
immunological defects in the gut-associated lymphoid tissues (Falk et al., 1998; 
Macpherson and Harris, 2004) as well as improper development of Peyer’s patches and 
mesenteric lymph nodes (Round and Mazmanian, 2009). Peyer’s patches and the 
mesenteric lymph nodes develop prenatally and isolated lymphoid follicles develop 
postnatally, but all of these tissues require interaction with key members of the gut 
microbiome in order to ensure proper differentiation and specification, and complete 
development of adaptive immunity (Cherrier and Eberl, 2012; Maynard et al., 2012). The 
immune system must maintain an anti-inflammatory state (Tsuji and Kosaka, 2008) in the 
gut, especially during exposure to the considerable number of innocuous antigens from 
commensals, hormones, and food. The interactions of diverse cell types are necessary to 
carry out the complex functions of the immune system (Adkins et al., 2004); we highlight 
several immune cell types with important dependencies on the gut microbiome. Dendritic 
cells (DCs), one of the most important types of antigen-presenting cells, sample the 
lumen and are responsible for orchestrating inflammatory or tolerogenic responses. To 
help the immune system carry out appropriate responses, DCs can suppress or induce the 
activation of antigen-specific T cells, and have the unique ability to differentiate naive T 
cells into effector or regulatory T cells to target specific antigens (Lanzavecchia and 
Sallusto, 2001; Macatonia et al., 1995). T helper cells are critical in processing presented 
antigens into specific cytokines that provide direction for other immune cells and to 
eventually generate an immunological response. Members of the gut microbiome have 
been found to differentiate The Th17 class of T helper cellssecrete IL-17 to produce 
defensins (Kao et al., 2004) and recruit neutrophils (Aujla et al., 2007) to fight infections 
at mucosal surfaces (Atarashi et al., 2008; Ivanov et al., 2009). Pro-inflammatory Th17 
cells must maintain balance with anti-inflammatory regulatory T cells, particularly for the 
prevention of autoimmune disorders. Certain Clostridia strains have been found to help 
with expansion and differentiation of regulatory T cells (Atarashi et al., 2013), and have a 
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direct role in reducing intestinal epithelial permeability by stimulating innate lymphoid 
cell and T cell production of cytokine IL-22 (Stefka et al., 2014). Innate lymphoid cells 
help induce pro-inflammatory responses and serve as the main source of IL-22 (Sawa et 
al., 2010); this cytokine is important for inducing mucus production from goblet cells, 
stimulating the production of antibacterial proteins, protecting cells from damage, and 
regulating cell differentiation (Sabat et al., 2014). A number of studies found that 
microbial signals modulate the amount of IL-22 produced by innate lymphoid cells 
(Sanos et al., 2009; Satoh-Takayama et al., 2008; Sawa et al., 2010; Sonnenberg et al., 
2012; Stefka et al., 2014; Vonarbourg et al., 2010), suggesting the importance of the gut 
microbiome in host defense mechanisms against infectious and inflammatory diseases 
(Rutz et al., 2013). Furthermore, Bifidobacterium longum has been found to assist in the 
maturation of DCs in Peyer's Patches and the development of T cells in the thymus (Dong 
et al., 2010). Specific microbial signals have been deemed necessary for proper education 
of regulatory T cells and invariant natural killer T (iNKT) cells (Hansen et al., 2012; 
Olszak et al., 2012), which are a subset of T cells capable of quickly inducing an 
abundance of cytokines that can stimulate or suppress a variety of immune responses. 
Additional important microbe-host interactions and mechanisms will be presented later in 
the context of our proposed model. Considering how critical the various immune cells 
and their intricate signaling networks are for supporting immune health, disruptions 
hindering their development may have lasting deleterious effects. 
Other major influences on microbiome development 
Diet plays a large role in the colonization of the modern infant GI tract due to the vast 
compositional differences between human milk and infant formula. The most notable 
difference in the microbiome of breastfed versus formula fed infants is the predominance 
of Bifidobacteria and Lactobacilli in breastfed infants, while formula-fed infants harbor 
more Enterococci and Enterobacteria (Palmer et al., 2007). There are also easily detected 
differences in total community membership between breastfed and formula-fed infants 
when looking at twin cohorts (Yatsunenko et al., 2012). Human milk is able to modulate 
bacterial colonization in the infant gut with distinct components not found in formulas: 
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the human milk microbiome, factors that stimulate bacterial growth (prebiotics), and 
factors that prevent bacterial growth (antimicrobials). The human milk microbiome 
consists primarily of Proteobacteria and Firmicutes (Nichols et al., 1974), and has of a 
core group of taxa found in most human milk samples that include Staphylococcus, 
Streptococcus, Serratia, Pseudomonas, Corynebacterium, Ralstonia, Propionibacterium, 
Sphingomonas, and Bradyrhizobiaceae (Hunt et al., 2011). The human milk microbiome 
also changes over time, and is dependent on the mother’s weight (Cabrera-Rubio et al., 
2012). For example, Weissella, Leuconostoc, Staphylococcus, Streptococcus, and 
Lactococcus are predominant in milk immediately after giving birth, and milk from obese 
mothers is less diverse than that of non-obese mothers (Cabrera-Rubio et al., 2012). 
These ingested bacteria provide a constant source of community members to help 
colonize the GI tract. Milk-borne prebiotics that modulate the bacteria present in the GI 
tract include human milk oligosaccharides (HMOs), which are sugars produced solely for 
consumption by microbes. These include the “original” HMO, bifidus factor (Nichols et 
al., 1974), that stimulates Bifidobacterium bifidum and hundreds of other sugars (all 
within a family of unconjugated glycans containing lactose at the reducing end) which 
primarily promote the growth of Bifidobacterium longum subsp. infantis (Bode, 2012). 
Antimicrobials in human milk that also influence the microbes within the GI tract include 
secretory immunoglobulin A (SIgA), which provides antigen-specific protection against 
microbes that the mother has already encountered (Rogier et al., 2014), and innate 
immune proteins, such as lactoferrin and lysozyme, that harbor bactericidal activity 
(Arnold et al., 1980). Milk obtained from mothers of preterm infants had highest 
concentrations of cytokines and immunoglobulins immediately after giving birth, further 
supporting the importance of breast milk consumption in early life (Moles et al., 2015). 
  
Mode of birth delivery has an impact on the microbiome of infants, as the total 
microbiome (skin, oral mucosa, and nasopharyngeal aspirate, and meconium) of 
vaginally delivered infants resembles the maternal vaginal and intestinal microbiome, 
while infants delivered by cesarean section have total microbiomes resembling the 
maternal skin microbiome (Dominguez-Bello et al., 2010). Specifically, the microbiomes 
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of vaginally delivered infants consist mostly of Lactobacillus, Prevotella, Atopobium, or 
Sneathia spp, whereas the microbiome of cesarean section delivered infants contain 
Staphylococcus spp (Dominguez-Bello et al., 2010) and less Bifidobacterium (Biasucci et 
al., 2010).  
Approaches for studying pediatric dysbiosis and related disease 
The mechanisms and health consequences of pediatric dysbiosis are complex and 
multifactorial, and are further complicated when also considering infant development 
(gut microbiome, immune system, and their interactions). Using a systems approach, we 
consider five interdependent models for understanding dysbiosis that focus on different 
aspects of disease mechanisms. We discuss these conceptual models in terms of their 
relative merits for clarity, potential for organization, and ability to express multi-factorial 
disease pathways. We restrict our hypotheses to those that assume long-term health 
effects of one or more short discrete courses of antibiotics, since that is by far the most 
common type of antibiotic exposure in human children (Gevers et al., 2014). Each 
perspective has strengths in its ability to generalize certain aspects of pediatric dysbiosis. 
In general, we find a combination of the dysbiosis-centric and disease-centric 
perspectives to be the most useful for discussing disease mechanisms. 
 
A Dysbiosis-centric view 
The gut microbiome is in constant flux; the community composition continuously adapts 
to environmental exposures and host developmental changes (Caporaso et al., 2011; 
Human Microbiome Project Consortium, 2012a). This adaptability is essential for 
maintaining gut homeostasis, but drastic changes, such as those induced by antibiotics, 
can potentially lead to negative health consequences. Pediatric dysbiosis can be 
characterized by these drastic changes in the microbial community, represented here as 
four distinct types. Since broad-spectrum antibiotics are designed to eradicate multiple 
bacterial taxa, the gut microbiome may be impacted by: (1) an unintended loss of 
keystone taxa that are critical for maintaining homeostasis or proper host development 
(e.g., immune system), or (2) an overall loss of biodiversity, which can have inherent 
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health risks on its own (e.g., the hygiene hypothesis) and also lead to other dysbiosis 
types (Figure 2.1). Taxa that have been eradicated from their niches leave vacancies to be 
filled by (3) blooms of pathogens and pathobionts. Even if the infant gut microbiome can 
recover from these dysbiotic states to arrive at some form of homeostasis, improper or 
partial recovery can result in a (4) shift in functional capability; for example, becoming 
more efficient at extracting energy (Figure 2.1). These dysbiosis types sometimes 
overlap, further adding to the complexity of the system and the challenge of building a 
unified conceptual model for pediatric dysbiosis research. Viewing pediatric dysbiosis 
from the perspective of different dysbiosis types is particularly important for 
understanding how small changes to the relatively simple infant gut can manifest as 
larger repercussions during adulthood. Such a dysbiosis-type model is crucial for 
understanding the community dynamics within the gut microbiome, but is limited in its 
ability to easily address several factors such as the age of the infant, the overlap and 
transition between dysbiosis types, the many-to-many relationship between dysbiosis 
types and disease phenotypes, and the parallel development of the immune system.  
 
A Disease-centric view 
In the context of different aspects of host development and specific taxa affected, the 
previously described pediatric dysbiosis types can give rise to a variety of health 
consequences. Deconstruction of the health outcome with a top-down approach is another 
model for understanding dysbiosis. In this disease-centered model, health outcomes are 
generalized by disease class, and then further characterized by specific mechanisms and 
interactions with subsystems of the model (host immune system, gut microbiome, host 
development, etc.) (Figure 2.1). For example, obesity-related pediatric dysbiosis in the 
context of this model begins with antibiotic treatment at any time point during the first 
two years of life. Biodiversity is depleted during treatment but rebounds after treatment 
ends, inducing large changes in taxonomic composition. In the case of obesity, these 
compositional changes also result in functional changes affecting metabolism; the 
microbiome becomes more efficient at extracting energy from multiple sources, and 
hence predisposes the host to obesity (Turnbaugh et al., 2006). Antibiotic exposure at a 
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younger age exacerbates predisposition to disease (Cox et al., 2014) and compounded 
disturbances may lead to unanticipated consequences (Paine et al., 1998). Other disease 
classes may include allergies and atopic diseases, autoimmune disorders, diabetes, and 
infectious disease. This model encapsulates major interdependencies within each disease 
class while accounting for temporal factors. The main shortcoming of the disease-centric 
view of pediatric dysbiosis is that it does not easily allow synthesis of common 
mechanisms across diseases. 
An Age-centric view 
Dysbiosis types can result in complete recovery with minimal impact to host health, or 
can have drastic unintended consequences depending on the stage of host development. 
Development of the microbiome and the host immune system can be categorized 
conveniently, although approximately, into four general stages: (1) 0 to 6 months, (2) 6 to 
12 months, (3) 12 to 24 months, and (4) 24 months and older. The infant is most 
vulnerable to developing immunological defects during Stage 1, when adaptive immunity 
interaction with keystone taxa is most critical (Prescott et al., 1999; Rautava et al., 2004; 
Van Der Velden et al., 2001). By Stage 4, the gut microbiome establishes a new-formed 
stasis as it reaches maturity, carrying forth any existing functional shifts that could 
predispose the host to future diseases. Although the vulnerabilities of each stage of 
development are important considerations for understanding dysbiosis, considering 
segregated stages hinders characterization of mechanisms that span multiple stages. 
  
A Response-centric view 
The gut microbiome transitions through several stages in response to a course of 
antibiotics: pre-treatment, during treatment, recovery, and long-term stasis (Figure 2.2a). 
Dysbiosis types that emerge during treatment include loss of keystone taxa and short-
term metabolic shifts, both of which would be compounded with multiple courses of 
antibiotics. Immediately after the antibiotic course, the gut microbiome begins to recover, 
but not without several potential complications. The loss of diversity imposed by 
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antibiotics may allow for blooms of pathogens and pathobionts; the adaptive immune 
system may be underdeveloped and keystone taxa may still not have recovered (further 
delaying immune development); and metabolic shifts may begin to take place. Eventually 
the gut microbiome reaches a form of stasis, which may be different from its pre-
treatment stage (Figure 2.2). At this stage, permanent metabolic shifts may have been 
established, a loss of biodiversity accompanied by a bloom of pathobionts may persist, 
and the host may be predisposed to an increased risk of infectious disease. Although the 
dynamics of the community structure in response to antibiotics are useful for identifying 
short-term vulnerabilities, mechanisms of dysbiosis typically start during one stage (e.g., 
treatment stage) and end in another (e.g., recovery stage), making this model difficult and 
confusing to work with. 
  
A Recovery-centric view 
Although adult gut microbiomes experience day-to-day changes, they are relatively stable 
when compared to infant gut microbiomes, which are characterized by large swings in 
taxonomic composition, especially throughout the first year of life. Regardless of the 
seemingly random shifts, there exists a clear trajectory of healthy development in the 
infant gut microbiome when assessing biodiversity and relative abundances of specific 
taxa (Figure 2.2). This model defines dysbiosis in terms of how the microbiome recovers 
back to this trajectory: fast recovery, slow recovery, or incomplete recovery (Figure 
2.2a). During fast recovery, there may be a short-term loss of diversity but keystone taxa 
are preserved and the gut microbiome quickly rebounds back to normal with little impact 
to the host. With a slow recovery, there may be loss of keystone taxa during a critical 
time for interaction with the immune system, therefore causing a delay in immune 
development. Biodiversity may be low and it may take some time before keystone taxa 
can reestablish and interact with the immune system before getting back on the normal 
trajectory. The host is most vulnerable to infectious disease during this prolonged state of 
recovery, with both an immature immune system and a low-diversity microbiome. 
Despite eventually recovering and reestablishing a healthy gut microbiome, the adaptive 
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immune system may have developed antibodies against commensals during the long 
recovery period, predisposing the host to autoimmune diseases. During an incomplete 
recovery, the compositional changes are so drastic that the gut microbiome reaches a 
completely new form of stasis, placing it on a trajectory completely different than 
expected (Figure 2.2a). These changes are accompanied by functional and metabolic 
shifts in the gut microbiome and come with disease risks of their own. The types of 
recovery in this model are not mutually exclusive since it is possible that either a fast or 
slow recovery rate may lead to an incomplete recovery. This model also does not address 
how a recovery type may be dependent on a specific development stage, as considered by 
the age-centric view. 
 
Current evidence for disease mechanisms 
In considering several alternative lenses through which to discuss and organize pediatric 
dysbiosis, we have decided to use a combination of the dysbiosis-centric and disease-
centric perspectives for summarizing and synthesizing existing knowledge about 
potential disease mechanisms (Table 2.1). This combined model allows us to map 
multiple causes to the same disease, while keeping track of different developmental and 
treatment stages that underlie the various known or proposed mechanisms. Although the 
causal pathway between dysbiosis and disease can take many forms, we present four 
important disease classes in major contributing dysbiosis types. 
Obesity 
Evidence for antibiotics-induced obesity is primarily characterized by shifts in functional 
capability, or more specifically, long-lasting metabolic shifts that result from incomplete 
recovery back to the normal trajectory. Recent work found that mice given sub-
therapeutic levels of antibiotics after weaning exhibited increased adiposity, large 
taxonomic changes in their gut microbiomes, and increased levels of short-chain fatty 
acids (SFCAs) as well as counts of bacterial genes involved in SFCA metabolism (Cho et 
al., 2012b). These mice also had lower caloric output in their faecal pellets despite dietary 
intake similar to controls, suggesting their gut microbiota developed the ability to extract 
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increased energy from indigestible components (Cho et al., 2012b). Furthermore, low-
dose antibiotics started even earlier in life (prior to weaning) resulted in mice showing a 
more pronounced increase of adiposity, and induced adipogenesis synergistically with a 
high fat diet; fecal transplantation into germ-free mice lead to increased fat mass relative 
to transplantation from mice without antibiotics, implicating the gut microbiome in the 
causal pathway of obesity (Cox et al., 2014). Some epidemiological studies further 
substantiate the long-lasting effects of early exposures, finding that antibiotic exposures 
among infants younger than six months are significantly associated with increased BMI 
later on in life, although in general these findings are somewhat mixed and warrant 
follow-up in a prospective study (Ajslev et al., 2011; Bailey et al., 2014; Trasande et al., 
2013). The 0-6 month window is a time of rapid host and microbiome development, yet 
also represents a period when the microbiome may be most susceptible to adopting long-
term changes. Additional studies, especially with human subjects, are necessary to 
understand how exposures during various developmental windows can alter the gut 
microbiome and host metabolism. 
Allergy and Atopic Disorders 
A considerable number of epidemiological studies link early antibiotic exposures, 
especially multiple courses, to atopic diseases later in life (Droste et al., 2000; Farooqi 
and Hopkin, 1998; Johnson et al., 2005; McKeever et al., 2002; Ong et al., 2014; 
Wickens et al., 1999). As mentioned previously, normal development of the immune 
system is dependent on key members of the gut microbiome for the development of 
regulatory components of the immune system as well as maintaining homeostasis at the 
gut epithelium. Allergic and atopic disorders are primarily caused by impaired 
components of the adaptive immune system that rely largely on the gut microbiome, for 
example B cell maturity (Lundell et al., 2014) and regulatory T cell differentiation and 
expansion (Atarashi et al., 2013). Distinct compositions of infant gut microbiomes have 
been associated with the development of atopic diseases later in life (Abrahamsson et al., 
2012; Atarashi et al., 2013; Bisgaard et al., 2011; Björkstén et al., 2001a; Kalliomäki et 
al., 2001); and therefore it is conceivable that early exposure to antibiotics, especially 
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broad-spectrum antibiotics, could be responsible for shaping the gut microbiome towards 
predisposition to allergy and atopic diseases. We hypothesize that two dysbiosis types 
may be responsible for allergy and atopic diseases: loss of keystone taxa and blooms of 
pathogens and pathobionts. Evidence for loss of keystone taxa has been shown in mouse 
studies, where antibiotic exposure led to changes in the gut microbiome, which 
eventually impacted the immune system. Reductions in regulatory T cell counts (Russell 
et al., 2012), and increases in serum IgE concentrations and basophil-associated TH2 cell 
responses (Hill et al., 2012) were observed with onset of the allergic disease phenotype. 
These observations agree with previous studies that found that an overabundance of IgE 
and the cytokine IL-4, produced by TH2 cells, are associated with allergies (Haas et al., 
1999; Jujo et al., 1992). Another study found that antibiotics given to neonatal mice 
reduced the abundance of Clostridia and as a result induced food allergies; clostridia 
colonization is important for stimulating IL-22 production to prevent food antigens from 
crossing the gut epithelium (Stefka et al., 2014). Microbial taxa considered important for 
immune development may differ from one developmental stage to the next, therefore 
warranting further investigation into the importance of timing of antibiotic exposure in 
atopic disease. Although some antibiotic exposures may only create short-term dysbiosis 
and eventually allow the microbiome to recover, if the period of dysbiosis coincides with 
critical developmental time points, there is potential for long-term impact on immune 
health. Several studies have indicated the first six months of life as the most critical for 
immune development (Prescott et al., 1999; Rautava et al., 2004; Van Der Velden et al., 
2001), suggesting the importance of host-microbiome interactions during this time. 
Germ-free mice have been shown to develop immune defenses against allergic asthma if 
colonized as neonates, but not if colonized in adulthood (Olszak et al., 2012). Similarly, 
Helicobacter pylori colonization in neonatal mice stomachs provided increased 
protection against asthma, compared to adult colonization (Arnold et al., 2011). 
Furthermore, Russell et al. induced asthma in mice with early antibiotic exposure but 
failed to reproduce the same phenotype with antibiotic exposure in adult mice (Russell et 
al., 2012). These studies suggest that antibiotic exposure during this critical window of 
development may have the most pronounced and long-lasting consequences. 
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In addition to the loss of keystone taxa, antibiotic exposure commonly results in an 
immediate reduction of biodiversity which may allow for unusual blooms of rare 
members of the gut microbiome. Blooms of certain strains of Clostridia, despite the 
importance of this taxa of bacteria in immune development, may actually contribute to 
atopic disease (Penders et al., 2013). Additionally, severe dysbiosis in a developing 
neonatal gut may allow for bacterial translocation of commensals and hence the 
development of systemic antibodies against these otherwise innocuous microbes. As seen 
in Crohn’s disease (Adams et al., 2008), it is highly plausible that inappropriate immune 
responses against commensals could also lead to hypersensitivity to common antigens, 
eventually leading to allergy and atopic diseases. 
  
Autoimmune diseases 
Although autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, and multiple 
sclerosis have a large genetic component, the gut microbiome has recently been found to 
be a potential major mediator of these diseases (Brown et al., 2011; Cani et al., 2008; 
Giongo et al., 2011; Lee and Mazmanian, 2010; Sellitto et al., 2012; Vaarala et al., 2008; 
Valladares et al., 2010; Wen et al., 2008). Autoimmune diseases result from an 
improperly developed immune system, which is, in part, mediated by the gut 
microbiome; there is evidence that germ-free mice are incapable of developing 
rheumatoid arthritis and multiple sclerosis (Lee and Mazmanian, 2010; Wu et al., 2010). 
In support of the hygiene hypothesis in autoimmune disease, one study found that the 
incidence of diabetes in non-obese diabetic mice raised in conventional breeding 
environments doubled when compared to pathogen-free breeding environments (Bach, 
2002), which suggests that antibiotics could exacerbate the onset of diabetes. Recent 
work found that the number of courses of antibiotics during childhood is associated with 
risk of juvenile rheumatoid arthritis (Horton et al., 2014), and the risk of inflammatory 
bowel disease (Hviid et al., 2011). There is also evidence that antibiotics are associated 
with celiac disease (Mårild et al., 2013). Studies examining the effects of antibiotic 
exposure on type 1 diabetes have yielded inconsistent results: one study found that 
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antibiotics given to non-obese diabetic mice during pregnancy modulated type 1 diabetes 
development in offspring (Tormo-Badia et al., 2014), but other studies found antibiotics 
to be protective (Brugman et al., 2006; Cani et al., 2008). There is currently limited 
evidence linking antibiotic exposures to autoimmune disorders, but we hypothesize that 
the underlying mechanisms are driven by loss of keystone taxa and blooms of pathogens 
and pathobionts, similar to those of allergy and atopic disorders due to the critical role of 
the immune system in these diseases. 
Infectious diseases 
Antibiotics are used to eradicate one or more bacterial taxa, therefore a temporary 
reduction in biodiversity is expected. Current studies report a large range of percent 
losses of biodiversity after antibiotic exposure (Figure 2.3), suggesting that some subjects 
may take longer to recover to baseline than others (Figure 2.2). The recovery period 
represents a vulnerable time for the host since not all members of the microbial 
community are present to suppress, potentially, blooms of pathogens and pathobionts, 
and hence prevent infection. A number of studies support this theory, showing an 
increased susceptibility of infection after antibiotic exposure (Croswell et al., 2009; 
Deshmukh et al., 2014; Lawley et al., 2008; Sekirov et al., 2008), with a number of 
studies highlighting the proliferation of antibiotic-resistant strains (Ayres et al., 2012; 
Brandl et al., 2008; Buffie et al., 2012; Donskey et al., 2000; Ubeda et al., 2010). 
Clostridium difficile infection in adults is an appropriate example of how loss of 
biodiversity enables blooms of pathogens in the gut. Necrotizing enterocolitis in pre-term 
infants has also been linked to antibiotic use prior to onset of disease (Alexander et al., 
2011; Cotten et al., 2009) and the gut microbiomes of children about to succumb to 
necrotizing enterocolitis exhibit decreased biodiversity and blooms of 
Gammaproteobacteria (Mai et al., 2011a; Wang et al., 2009). Although pre-term infants 
have a distinct set of health risks, this mode of infection can be extended to other disease 
agents in full-term infants as well (Figure 2.2b). This need for ecological checks and 
balances in the gut microbial community extends beyond its bacterial members; 
antibiotic-induced dysbiosis has been shown to impair innate antiviral immunity against 
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the influenza virus (Abt et al., 2012) as well as to enable blooms of opportunistic fungi, 
such as Candida albicans (Noverr et al., 2004; Seelig, 1966; Sharp, 1954; Torack, 1957). 
Longer-duration antibiotic therapy appears to be correlated with length of recovery 
period (Fouhy et al., 2012), which also increases the risk of infection (Alexander et al., 
2011). Identifying when a microbiome is fully recovered will be challenging given the 
inter-individual deviations of the adult gut microbiome, and will be even more difficult 
with the highly variable, developing infant gut microbiome. Lawley et al. found that mice 
exposed to antibiotics still exhibited increased colonization of Salmonella Typhimurium 
despite recovery of bacterial counts (Lawley et al., 2008), suggesting that not only is 
microbiome recovery challenging to define, but that current methods for measuring 
biodiversity may be insufficient for assessing infection risk. Although previous studies 
have focused on short-term risks for infection, it also is plausible that antibiotic exposure 
could lead to an incomplete, yet stable and permanent, recovery of the microbiome 
(Dethlefsen et al., 2008), potentially predisposing the recipient to infectious disease later 
in life. 
Future directions 
The model presented here links together the existing epidemiological and mechanistic 
studies on antibiotics and various gut-mediated disease outcomes. Large, integrated 
studies designed to focus on short- and long-term impact of antibiotics, both in terms of 
microbiome composition and in terms of disease risk, with careful consideration of the 
factors presented here, will be critical as we move toward an increased understanding of 
related disease etiologies. Such studies will enable important applications, such as the 
development of diagnostic tools to discover complex microbial biomarkers for dysbiosis 
risk. To demonstrate the potential importance, using a machine learning model trained on 
existing data (Knights et al., 2011a; Yatsunenko et al., 2012), we developed a 
Microbiome Maturity Index capable of accurately predicting the age of healthy infant gut 
microbiomes within 1.3 months (standard error) (Figure 2.4). Similar models have 
already been shown to be successful in identifying dysbiosis; Subramanian et al. used 
similar methods and found that children with severe acute malnutrition had gut 
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microbiomes that were significantly immature compared to healthy children 
(Subramanian et al., 2014). There is enormous potential for the microbiome field to 
revolutionize diagnostics and therapeutics, yet published human infant studies have not 
been designed to infer causality. Establishment of a large and diverse baseline cohort to 
define healthy development of the infant microbiome in presence and absence of 
perturbation by caesarian delivery, breast-feeding alternatives, and antibiotic usage is 
essential to refine our understanding of “normal development” so that pediatric dysbiosis 
can be identified robustly. Additionally, longitudinal and cross-sectional studies assessing 
the short-term, mechanistic, and longer-term health impact of antibiotics will be 
necessary to advance the diagnosis, interpretation, and treatment of pediatric dysbiosis, 
and to provide evidence-based recommendations regarding safe practices for antibiotic 
usage in infants. 
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The microbiome research field consists of a wide variety of complex datasets; as a result, 
there does not yet exist a single gold standard bioinformatics pipeline for analyzing and 
interpreting data generated from these studies. In preparation for our human study in 
Chapter 5, we validated a series of statistical models and computational tools against 
published datasets to measure effect sizes and to select methods that were most robust. 
As a result of these efforts, we generated a large set of curated microbiome datasets, 
which we have made publicly available for other computational scientists. 
 
Introduction 
Machine learning is widely used as a method for classification and prediction, with a 
growing number of applications in human health (Jordan and Mitchell, 2015). The use of 
machine learning in biological fields (Furey et al., 2000; Shipp et al., 2002), and more 
specifically the microbiome research field (Aagaard et al., 2012; Knights et al., 2011b; 
Smith et al., 2013; Yatsunenko et al., 2012), has grown exponentially due to the 
robustness of these algorithms to high dimensional data. In addition, large-scale meta-
analyses often requires manual curation of metadata and standardized processing of raw 
sequence data, resulting in variation in chosen datasets across studies (Pasolli et al., 2016; 
Sze and Schloss, 2016). Unfortunately, the resulting processed data is often not shared 
due to the use of previously published data inherent to meta-analyses. This results in 
inefficiencies in the manual steps of metadata curation. In addition, microbiome research 
data can be challenging to access for expert machine learning algorithm developers, who 
often do not have the domain expertise required to parse the metadata in complex studies. 
The University of California Irvine (UCI) Machine Learning Repository (Asuncion and 
Newman, 2007) revolutionized machine learning methods development by giving 
developers access to many curated datasets; its widespread usage and impact can be seen 
from its thousands of resulting citations. Currently, we are unaware of any machine 
learning repository that offers access to microbiome datasets. We constructed a 
complementary database to address this deficiency, and hope that it will promote the 
development of and usage of improved machine learning methods for the microbiome 
community. 
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Workflow 
We present the Microbiome Learning Repo (ML Repo), a repository of 33 curated 
classification and regression tasks using human microbiome data. Our 33 tasks are 
curated from 15 publicly available human microbiome datasets, which include 12 
amplicon-based and 3 shotgun sequencing datasets (Table 3.1). These datasets vary 
across sequencing technology platforms, 16s hypervariable regions, and study design, in 
order to help developer ensure robustness of algorithms across data types. We 
streamlined the microbiome data using a single post-processing workflow (Figure 3.1A). 
We downloaded trimmed and quality filtered sequencing reads for n=8 datasets from 
QIITA (Qiita Development Team), and raw sequences for n=7 datasets from public 
repositories. We preprocessed raw sequences using SHI7 (Al-Ghalith et al., 2018) or 
QIIME (Caporaso et al., 2010) according to individual technologies and characteristics of 
each study. Full details regarding the data preprocessing are provided for each data set in 
the repo. We picked Operational Taxonomic Units (OTUs) from all quality filtered 
sequences using a closed-reference method with the BURST (Al-Ghalith and Knights, 
2017) aligner against both the NCBI RefSeq 16S ribosomal RNA project (O’Leary et al., 
2016) and the Greengenes 97 database (McDonald et al., 2012). Samples with depths 
lower than 1000 sequences per sample were dropped for n=10 datasets, while we applied 
a lower threshold of 100 sequences per sample for n=5 datasets which had lower 
expected bacterial load. As a result, for each dataset we generated RefSeq-based OTU 
and taxa abundance counts, and Greengenes-based OTU and taxa abundance counts. We 
excluded additional post-processing filtering and normalization steps so that these 
parameters can be included in future benchmarking use cases as needed. We also limit 
our data to OTU and taxa tables as other metrics such as alpha and beta diversity can be 
subsequently generated as needed. 
  
Sample metadata from individual studies were manually curated to generate viable 
prediction tasks. When available, published study exclusion criteria was applied 
accordingly and confounders were removed by dropping samples or stratification. Studies 
that were cross-sectional by design but contained several samples per subject were 
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filtered to contain one sample per subject. Well-known confounders, such as geography, 
were accounted for when constructing prediction tasks for other human-associated 
conditions. Longitudinal studies were reduced to single time points of interest to 
minimize the effect of high intra-individual similarities. Hence, each prediction task is 
made available as an individual, compartmentalized metadata file that contains sample 
identifiers, responses to predict, and optionally, confounder variables to control for. As a 
result, we generated 33 distinct tasks for predicting human-associated responses. 
 
Methods 
 
Pre-processing of sequencing reads 
When available, preprocessed FASTA files were downloaded from QIITA (or previously, 
the QIIME database). For all other datasets, raw FASTQ files were downloaded from 
sources listed in Table 3.1. Sequences were trimmed and quality filtered using SHI7 (Al-
Ghalith et al., 2018) or QIIME (Caporaso et al., 2010). OTUs were picked from 
processed FASTA files using BURST (Al-Ghalith and Knights, 2017) with Greengenes 
(McDonald et al., 2012) 97 or the NCBI RefSeq Targeted Loci Project 16s project 
(O’Leary et al., 2016) (accessed on 17-07-04). Samples with sequencing depth lower than 
1000 sequences per sample were dropped for all studies, except for five datasets (David 
et al., 2014; Gevers et al., 2014; Human Microbiome Project Consortium, 2012b; Kostic 
et al., 2012; Turnbaugh et al., 2009b), where the minimum threshold was 100 sequences 
per sample. 
  
Selection of classification tasks 
Classification tasks were selected based on reported study results, biologically relevant 
high-level phenotypes, and sufficient sample sizes. Original metadata files and research 
methods were rigorously and manually curated in order to subset samples with minimal 
confounders. For confounders that were inherent to the study, we include an additional 
variable to control for in the task metadata files. Presence of control variables can be 
found by examining “control_vars” in the Tasks table. 
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Website generation 
Website templating was developed using Jinja2 (Ronacher, 2017) and custom Python 
scripts. Individual webpages were generated by iterating through items in the Tasks and 
Datasets tables, and dynamically populating templates in order to generate individual 
Markdown (Gruber et al., 2004) pages. The resulting Markdown pages are hosted as 
GitHub Pages. 
  
Case Study Benchmarking 
Case study results were generated with custom R (Team and Others, 2013) scripts, which 
can be found in the /example folder in the MLRepo Github repository. To compare 
machine learning models, we iterated through tasks with binary responses. OTU counts 
were converted to relative abundances, filtered at a minimum of 10% prevalence across 
samples, and collapsed at a complete-linkage correlation of 95%. We then constructed a 
5-fold cross-validation for tasks containing more than 100 samples, or a leave-one-out 
cross-validation for tasks with smaller sample sizes. For n-fold cross validation, samples 
were assigned to folds such that classes were equally balanced within each fold (e.g. if 
our task contained 40% healthy and 60% diseased samples, our folds would also be 
selected to represent this distribution). For tasks that contained control variables, we 
selected folds such that samples with the same control variable value were contained 
within the same fold. For example, for a task dataset containing matching stool and oral 
samples from subjects, the Subject Identifier would be listed as the control variable and 
we should assign samples to folds such that all samples from a specific subject were 
contained within a fold. This step is crucial to avoid biasing or overfitting the training 
model; test folds should contain not only new samples, but also samples that are 
independent from those in the training set. Models were constructed using the ‘caret’ 
package (Kuhn and Others, 2008). This process was bootstrapped 100 times, and the 
mean class probabilities were used to calculate the resulting AUCs and ROCs. To 
compare classification accuracies using different reference databases, we used a similar 
procedure but held the model constant and predicted using different base OTU tables. 
This model enables comparison of a myriad of machine learning models available in the 
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‘caret’ package, and can be easily expanded to compare different OTU-picking 
algorithms, or normalization and filtering techniques. 
Publicly available web-based interface 
We expect two types of users: (1) machine-learning algorithm developers with limited 
knowledge of microbiome study designs and (2) microbiome researchers interested in 
obtaining additional datasets for meta-analysis. Generally, we expect that methods 
developers will be most interested in sweeping through the full set of prediction tasks for 
benchmarking, and hence would prefer to download a single compressed file containing 
all tasks and data. On the other hand, we expect that microbiome researchers will be more 
selective in downloading specific datasets and tasks depending on their research domain. 
Hence, researchers may prefer to browse specific details about tasks and datasets prior to 
downloading. 
  
Based on these expected use cases, we created a publicly available web-interface for 
MLRepo hosted by GitHub Pages and available at: https://knights-lab.github.io/MLRepo. 
Tasks are organized by relevant response categories (Figure 3.3A). Task pages contain 
descriptive details such as Sample Size and Response Type that are specific to the 
selected prediction task, as well as links for downloading OTU tables, taxa tables, and 
sample metadata (Figure 3.3B). Dataset pages contain important details about the entire 
dataset, including links to the original research study, as well as original metadata files 
and quality filtered sequences (Figure 3.3C). We also provide a single compressed file 
containing the entire set of available tasks (OTU tables, taxa tables, and relevant 
metadata) for download from the main home page. 
Benefits of curated microbiome-based prediction tasks 
We expect MLRepo to be beneficial for both the machine-learning community as well as 
the microbiome research community. MLRepo will be a powerful complement to UCI’s 
machine learning repository, as it will allow for benchmarking curated classification tasks 
with high-dimensional data, and hence enable the subsequent development of novel 
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algorithms for these complex datasets. Our streamlined approach in generating OTU and 
taxa tables offers a rich set of 15 datasets that microbiome researchers can use directly for 
further comparison with their own studies, for teaching and learning purposes, or for 
large meta-analyses. We expect that our provided OTU and taxa tables will also be 
beneficial for researchers with limited access to high-performance computing resources 
or bioinformatics skills necessary for processing raw sequencing data. In addition, we 
expect microbiome-specific methods development will also benefit from our repository 
prediction tasks. The subsetted samples found in each prediction task metadata file 
replaces the work of rigorously deciphering metadata and nuances from individual 
research studies. Hence, new methods, such as OTU-picking algorithms, can be evaluated 
not only on metrics such as speed and accuracy, but also based on overall impact to study 
findings. 
Comparison to similar databases 
Although a number of microbiome repositories exist, many are intended as data archival 
repositories (Hunter et al., 2014; Leinonen et al., 2011) or function as resources for 
aggregating across studies (Forster et al., 2016). Resources such as QIITA (Qiita 
Development Team) offer an extensive collection of datasets, and mock-community-
based Mockrobiota (Bokulich et al., 2016a) is well-suited for benchmarking upstream 
methods, but neither offer support for the metadata interpretation necessary for predicting 
high-level phenotypes. MLRepo differs from all of these resources in that we provide 
well-defined tasks for predicting responses from manually curated metadata and 
standardized data from published microbiome research studies. 
Case studies 
We compare the performance of three machine learning models: random forest (Breiman, 
2001), and support vector machine (Cortes and Vapnik, 1995) (SVM) with either a radial 
or linear kernel. Sweeping through available tasks with binary responses, we compare our 
models by examining receiver operating curves (ROCs) and areas under the curve (AUC) 
(Figure 3.4). Through direct comparison of ROCs, we can see that random forest 
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outperforms or ties the other two models in 21 out of the 28 tasks. The choice of kernels 
appears to have limited impact on overall mean accuracy, yet a linear kernel can perfectly 
classify penicillin-treated and vancomycin-treated mouse cecal contents when the other 
models could not; further examination of the microbial features in these samples may be 
warranted to further understand the strengths of this kernel. We also directly compared 
AUC and accuracy of the models across all tasks and, although not statistically 
significant (P=0.065 and P=0.15, respectively), found that random forest in general does 
better than the other two models (Figure 3.5A). Our results support the broad usage 
(Aagaard et al., 2012; Karlsson et al., 2013; Pasolli et al., 2016; Yatsunenko et al., 2012) 
and acceptance of random forest as a robust classifier (Knights et al., 2011b) with high-
dimensional microbiome data. 
  
We also used the classification tasks to assess the impact of reference database choice on 
classification accuracies by comparing random forest using OTUs picked with the 
Greengenes 97 database or the NCBI RefSeq Targeted Loci Project 16s project. We find 
that there is limited impact of database choice to overall classification accuracies (Figure 
3.5B). This may be due to (1) large effect sizes that are driven mainly by several well-
characterized bacterial taxa present in both databases (e.g. stool versus tongue samples), 
or (2) small effect sizes such that classification is difficult regardless of the database (e.g. 
male versus female stool). 
  
Future Work 
In the future, we expect and hope that the broader microbiome research community will 
add new datasets and prediction tasks to MLRepo. We provided instructions on our 
GitHub repository to guide users to create a fork from our repository, add the appropriate 
data and files, and update the master task and dataset lists. Users can then submit a pull 
request for our review, and if properly formatted, will be accepted and merged into the 
repository. We expect that data submissions will come from either the original 
researchers or those well-acquainted with the datasets, and hence will expect that sample 
selection and subsetting will have undergone rigorous review for prediction tasks. 
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Conclusions 
We developed MLRepo, a repository of curated microbiome datasets made available for 
the computational community, and presented several case studies for how it can be a 
valuable resource. We hope that this repository will promote the development of and 
usage of improved machine learning methods for the microbiome community. 
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Although broad-spectrum antibiotics, commonly used in western medicine, can lead to 
imbalances in the gut microbiome, this chapter builds upon the examination of other 
western exposures that may be detrimental to the gut microbiome. 
 
Introduction 
Previous work has established that diet and geographical environment are two principal 
determinants of microbiome structure and function (De Filippo et al., 2010; Febinia, 
2017; Gomez et al., 2016; Kwok et al., 2014; Obregon-Tito et al., 2015; Rothschild et al., 
2018; Schnorr et al., 2014; Yatsunenko et al., 2012). Rural indigenous populations have 
been found to harbor substantial biodiversity in their gut microbiomes, including novel 
microbial taxa not found in industrialized populations (Clemente et al., 2015; Gomez et 
al., 2016; Obregon-Tito et al., 2015; Schnorr et al., 2014; Smits et al., 2017; Yatsunenko 
et al., 2012). This loss of indigenous microbes or “disappearing microbiota” (Blaser and 
Falkow, 2009) may be critical in explaining the rise of chronic diseases in the modern 
world. Despite the frequent migration of people across national borders in an increasingly 
interconnected world, little is known about how human migration may affect intricate 
human-microbe relationships. 
 
The United States (U.S.) hosts the largest number of immigrants in the world (49.8 
million or 19% of the world’s total immigrants and approximately 21% of the U.S. 
population) (Department of Economic and Social Affairs, Population Division, 2017). 
Epidemiological evidence has shown that residency in the U.S. increases the risk of 
obesity and other chronic diseases among immigrants, with some groups experiencing up 
to a four-fold increase in obesity after 15 years (Bates et al., 2008; Cairney and Ostbye, 
1999; Goel et al., 2004; Kaplan et al., 2004; Lauderdale and Rathouz, 2000; Walker et al., 
2008). This “healthy immigrant effect” has been well-documented in Western countries 
(Antecol and Bedard, 2006), and is attributed to many complex, interacting factors, the 
effects of which vary depending on the immigrant subpopulation (Barcenas et al., 2007). 
Refugees, in particular, appear to be more vulnerable to rapid weight gain (Heney et al., 
2014; Hervey et al., 2009), with Southeast Asian refugees exhibiting the highest average 
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increases in body mass index (BMI) (Careyva et al., 2015) after relocation to the U.S. 
Minnesota is home to the highest number of refugees per capita in the U.S., and has 
experienced the largest wave of refugees during the last decade (Koumpilova, 2015). The 
Hmong, a minority ethnic group from China who also reside in Southeast Asia, make up 
the largest refugee group in Minnesota (22,033 total refugees as of 2014) (Minnesota 
Department of Health), and also form the largest centralized Hmong community in the 
U.S. (70,000 total individuals) (Pfeifer and Thao, 2013). The Karen, an ethnic minority 
from Burma, have been arriving in large numbers in more recent years (Minnesota 
Department of Health). Although the Hmong and Karen originate from different 
countries, have distinct backgrounds, and arrived in the U.S. at different times, many in 
these groups share a common path through refugee camps in Thailand; they may also 
share similar disease disks in the U.S. Refugee children from Burma exhibited the 
steepest BMI increase after relocation, compared with other refugee and non-refugee 
children (Dawson-Hahn et al., 2016); to our knowledge, disaggregated data on long-term 
health changes in ethnic Karen from Burma do not yet exist. Overweight status and 
obesity rates are highest among Hmong compared to other Asian ethnic groups in 
Minnesota (Arcan et al., 2014; Franzen and Smith, 2009; Himes et al., 1992; Mulasi-
Pokhriyal et al., 2012), and Western diet acculturation, previous exposure to food 
insecurity, and physical inactivity have been identified as contributing factors (Franzen 
and Smith, 2009; Mulasi-Pokhriyal et al., 2012; Smith and Franzen-Castle, 2012). 
 
The gut microbiome plays a critical role in host metabolism and is heavily influenced by 
an individual’s long-term diet (Hildebrandt et al., 2009; Wu et al., 2011), yet can also 
quickly respond to dramatic dietary changes (David et al., 2014; Turnbaugh et al., 
2009a). Hence, the gut microbiome serves as an important window into the consequences 
of diet and lifestyle changes associated with migration. To study the short- and long-term 
impact of migration on the microbiome, we measured gut microbiomes and dietary intake 
from Hmong and Karen immigrants and refugees (henceforth referred to as immigrants) 
across cross-sectional and longitudinal cohorts undergoing relocation to the U.S. We 
characterized gut microbiome species, strains, and functional profiles among Hmong and 
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Karen individuals still living in Thailand and after U.S. immigration. The cohort was 
stratified by BMI to include cross-sectional samples from individuals with high (≥25) and 
low (<25) BMI in both pre- and post-immigration groups. The first-generation immigrant 
(foreign-born U.S. residents) group included individuals with duration of U.S. residence 
ranging from a few days to more than 40 years. This range allowed us to test for changes 
in the gut microbiome associated with long-term residence and duration of residence. We 
then studied second-generation (born in the U.S. to first-generation immigrants) Hmong 
immigrants to determine whether the effects of U.S. immigration are compounded across 
generations by birth in the U.S. Finally, we followed a longitudinal cohort of 19 Karen 
refugees for 6 months beginning immediately before or after arrival in the U.S to measure 
the immediate short-term effects of U.S. immigration. 
 
Methods 
 
Study setting, population, and recruitment.  
Our inclusion criteria included individuals who were Hmong or Karen, female, at least 18 
years old, and either were born and are currently living in Thailand, were born in 
Southeast Asia and moved to the U.S., or were born in the U.S. but whose parents were 
born in Southeast Asia. Our inclusion criteria for controls included Caucasian females at 
least 18 years of age who were born in the U.S. and whose parents and grandparents were 
also born in the U.S. Our exclusion criteria consisted of use of any antibiotics in the 
previous 6 months, current use of probiotic supplements, known presence of 
gastrointestinal, cancer, immunodeficiency or autoimmune disorders, adults lacking 
capacity to consent, or pregnancy. Additionally, control subjects could not have traveled 
outside of the U.S. within the last 12 months. We recruited using multiple methods which 
included flyers, emails, social media, oral presentations, tabling, letters followed by 
phone calls to West Side Community Health Services (West Side) patients who met 
criteria, and by word of mouth. We recruited throughout the Minneapolis-St. Paul metro 
area at local community centers, faith-based organizations, adult education centers, health 
care centers, and health fairs. We recruited in Thailand at Khun Chang Khian (KCK), a 
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rural Hmong village located one hour from Chiang Mai city, as well as from Mae La 
(ML) Camp, a Burmese refugee camp in Tak province located on the Myanmar-Thailand 
border (Figure 4.S1). Interested subjects were then screened and interviewed privately or 
as a group, as preferred by the participants. Interviews and body measurements were 
conducted by trained Hmong and Karen community researchers and a graduate student 
researcher. This study was approved for human subject research by the University of 
Minnesota Institutional Review Board (1510S79446), and the Thailand-based portion of 
the study was additionally approved for human subject research by the Chiang Mai 
University Institutional Review Board (475/2015) and the Chiang Mai Public Health 
Office (0032.002/9930). 
 
Application of Community-based Participatory Action Research methods 
This project used a community-based participatory action research (CBPAR) approach, 
with a multidisciplinary team composed of academic researchers, Hmong and Karen 
community researchers, and staff from the Somali, Latino and Hmong Partnership for 
Health and Wellness (SoLaHmo). SoLaHmo is a multi-ethnic, community-driven 
CBPAR program of West Side Community Health Services, Inc, whose mission is to 
build upon the unique cultural strengths of ethnic communities to promote health and 
wellness through research, education and policy. All SoLaHmo members are trained in 
qualitative research processes using a previously developed training curriculum (Allen et 
al., 2011). In addition, all phases of our project were further guided by community 
advisory boards (CABs) composed of Hmong and Karen health professionals and 
community experts. The study design, recruitment methods and strategies, and 
dissemination of results were developed in partnership with both academic and 
community researchers, and through multiple discussions with the CABs. Based on 
insight from the Hmong CAB and research team members that substantially more Hmong 
women than men were relocating to U.S. in recent years, we limited our study to women. 
In Thailand, we used a modified CPBAR approach in that Thai community researchers 
were members of the communities that we worked with, and were trained with qualitative 
research methods, recruitment, and sample and data collection, but were not directly 
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involved with study design. We note that Hmong refugee camps have long been closed 
(Bureau of Population, Refugees and Migration, 2004), hence Hmong in Khun Chang 
Khian are not refugees but serve as acceptable pre-immigration representatives available 
for US-based Hmong.  
 
Cross-sectional specimen and data collection, U.S.  
Research team members obtained informed consent and conducted interviews in the 
participants’ preferred languages (English, Hmong, or Karen), and recorded participants’ 
responses onto an English paper survey (Appendix A). Weights were measured using 
standard electronic scales, heights were measured against a wall using a pre-positioned 
measuring tape, and waist circumferences were measured with a tape measure at the 
uppermost lateral border of the iliac crest (Center For Disease Control, 2014). 24-hour 
dietary recalls were conducted using a multiple pass system (Tippett et al., 1999) with 
food models and measuring cups and spoons for portion size estimations. Participants 
were provided with a stool collection kit and instructions describing how to collect a stool 
sample. Stool samples were collected into preservative (see below) and were either 
returned to the research staff by mail or were stored at room temperature for up to 5 days 
before they were collected by the research team. 
 
Longitudinal specimen and data collection, U.S.  
Procedures for consent, interviews, anthropometrics, and stool sampling were as 
described above for the cross-sectional specimen and data collection. Once per month 
over six months, 24-hour dietary recalls were conducted as described previously. Month 
1 and 6 samples were stored in a home freezer and picked up within 24 hours of stool 
collection. These samples were transported with an ice pack and immediately placed in a 
-80C freezer. Month 2-5 samples were stored in preservative (see below), mailed to the 
research team in prepaid mailers at room temperature, and placed in a -80C freezer upon 
receipt. 
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Specimen and data collection, Thailand 
Procedures for consent, interviews, anthropometrics, and stool sampling were as 
described above for the cross-sectional specimen and data collection. 24-hour dietary 
recalls and sample collections were conducted as described previously. Stool samples 
from KCK were transported on dry ice then placed in a -20C freezer for 2 days then 
transferred to a -80C freezer. Stool samples from ML were placed in a -20C freezer for 
up to 8 hours then transferred to a -80C freezer. All samples collected in Thailand were 
shipped overnight on dry ice from Thailand to the U.S., and stored in a -80C freezer in 
the U.S. 
 
Stool sample collection 
Research team members instructed participants in stool collection, using an instructional 
video, written visual instructions, and verbal reinforcement. Participants placed their 
stool sample onto a FecesCatcher (Tag Hemi VOF) and 1 gram was collected using a 
sterile swab into a 1.5 ml cryogenic tube pre-filled with 900 ul of RNALater™ and mixed 
thoroughly, (Appendix B). Larger samples (longitudinal first and last month samples) 
were collected using a Sarstedt Inc 80.9924.014/CS500 tube and scoop without mixing or 
RNALater. Large samples collected in the U.S. were aliquoted into 1.5 ml tubes with and 
without 50% glycerol upon arrival, and stored at -80C. Large samples collected in 
Thailand were stored at -80C until arrival to the U.S., at which point they were thawed 
over ice, aliquoted, and stored in the same manner.  
 
Dietary data processing workflow 
De-identified survey data was entered into an electronic spreadsheet. Foods and portions 
from 24-hour dietary recalls were entered into the USDA SuperTracker system (Britten, 
2013). Foods that were not found in the USDA database were researched individually 
(Speek et al., 1991) for macronutrient content and entered in as custom foods. 
SuperTracker macronutrient and food grouping summaries, as well as foods and their 
respective portions were downloaded directly from the SuperTracker website, or using 
custom Python (van Rossum and Drake, 2011) scripts. Foods and portions were mapped 
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to the SuperTracker and USDA databases to obtain respective food and portion 
identification numbers; food and portion identification numbers were used in tree-based 
food analysis. Custom foods not in the USDA database were manually assigned 
appropriate existing or new food identification numbers by group consensus. 
Micronutrients were excluded from dietary analyses due to the high number of custom 
foods with limited information on micronutrients. Food tree visualizations were 
generated with Graphlan (Asnicar et al., 2015). Dietary record and food item associations 
were generated using custom scripts, then visualized in Cytoscape (Shannon et al., 2003). 
 
16S sample processing and sequencing 
All fecal samples were submitted to the UMN Genomics Center for DNA extraction, 
amplification, and sequencing. 16S ribosomal rRNA gene sequences were extracted and 
amplified following the UMGC-developed protocol (Gohl et al., 2016). We trimmed and 
processed all marker-gene sequencing data for quality using SHI7 (Al-Ghalith et al., 
2018) and picked de novo operational-taxonomic units (OTUs) as follows. We first 
filtered for reads with at least 100 exact duplicates as representative sequences, and 
assigned taxonomy by alignment at 0% to the NCBI RefSeq 16s reference database 
(O’Leary et al., 2016) using the BURST (Al-Ghalith and Knights, 2017) OTU-picking 
algorithm in CAPITALIST mode, which ensures optimal alignment of sequences and 
minimizes the set of aligned reference genomes. All original sequences were then re-
aligned with BURST (Al-Ghalith and Knights, 2017) in CAPITALIST mode at 98% 
identity against this representative set, resulting in 93.54% of all available sequences 
aligned. Singleton OTUs and samples with depth less than 2,143 were removed using the 
Quantitative Insights Into Microbial Ecology (QIIME) software package (Caporaso et al., 
2010). Using QIIME, we measured within-sample biodiversity (alpha diversity) with 
rarefied OTU tables (at 2,143 sequences/sample) using whole-tree phylogenetic diversity 
(Faith, 1992) and a custom generated phylogeny constructed with the representative 
sequences using aKronyMer (Al-Ghalith and Knights, 2018). To quantify differences in 
composition between subjects, we calculated the phylogeny-based UniFrac distance 
(Lozupone et al., 2011) between all pairs of samples. To visualize between-subject 
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differences (beta diversity) and to obtain principal components for subsequent statistical 
testing, we performed dimensionality reduction using principal coordinates analysis 
(Caporaso et al., 2010). Aitchison’s distances were calculated by first imputing zeros 
from an abundance OTU table, then applying a centered log ratio transform using the 
robCompositions R package (Pawlowsky-Glahn and Buccianti, 2011). To enable tests for 
shifts in the relative abundances of Bacteroides and Prevotella, we collapsed the 
reference-based OTUs according to taxonomy at the genus level.  
 
Deep shotgun metagenomic sample processing and sequencing 
Shotgun DNA sequencing was performed on the Illumina HiSeq platform. All fecal 
samples were submitted to the UMN Genomics Center for DNA extraction, 
amplification, and sequencing. Amplification, quantification, and normalization of 
extracted DNA was performed using the Illumina NeoPrep Library System. A HiSeq 
2x125 cycle v4 kit was used to sequence samples. Sequences were identified at the 
species level via genomic alignment against a custom database created from aligning 
human samples from various public datasets against the comprehensive NCBI RefSeq 
database (Tatusova et al., 2013) release 87, and all matched bacterial species, as well as 
all species in matched representative genera, were included from NCBI RefSeq database 
(Tatusova et al., 2013) release 87. Genome coverage estimates were calculated using the 
bcov utility from BURST (Al-Ghalith and Knights, 2017). Functional annotations were 
obtained using the HUMAnN2 (Abubucker et al., 2012) pipeline with UniRef50 (Suzek 
et al., 2015). Resulting functional pathways were mapped to and colored by the top level 
categories of the MetaCyc (Caspi et al., 2008) ontology. CAzyme annotations were 
obtained using metaSPAdes (Nurk et al., 2017), filtered for scaffolds with minimum 1000 
bp, then further processed with Prokka (Seemann, 2014), dbCAN (Yin et al., 2012) with 
E-value < 1e−5, and the CAZy database (Lombard et al., 2014).  
 
Food-Microbiome Procrustes distance associations 
Procrustes: P-values are from the `vegan` implementation in function `protest ()` with 
999 permutations (performed for each of the permuted data structures). Distances plotted 
 48 
are the Euclidean distances between food and diet samples after rotation of distance 
matrices with Procrustes. The representative Procrustes plot with permuted labels was 
chosen based on median overall Procrustes distance (M12 = square-root of 1 minus the 
sum of squares) out of 10 permuted Procrustes rotations. 
 
Predicted biosynthetic gene clusters 
Raw shotgun reads were quality controlled using SHI7 (Al-Ghalith et al., 2018) and 
aligned using BURST (Al-Ghalith and Knights, 2017) at 95% identity against a reference 
database of 21,186 putative biosynthetic gene clusters (BGC) predicted by antiSMASH 
or deposited in the MIBiG database (Blin et al., 2017; Weber et al., 2015). The per-
sample metagenomic coverage of each BGC was calculated using in-house Python and R 
code and filtered to pathways with a ratio of actual coverage to expected coverage 
(expected coverage probability is defined as 1-exp ( (N * L_read )  ⁄ L_BGC ), where N = 
number of reads, L_read = median read length, and L_BGC = BGC sequence length) of 
at least 0.75. Differentiating BGCs were identified by comparing BGC presence/absence 
frequency between the treatment groups using Fisher’s exact test with FDR correction at 
q < 0.15. To collapse homologous BGCs we used custom Python and C code to 
hierarchically cluster the pathways based on amino acid identity and open reading frame 
composition (Rashidi et al., 2018; Shields-Cutler et al., 2018; Zhang et al., 2018). Cluster 
annotations and taxonomic assignments were derived from their antiSMASH references.  
 
Mouse experiment specimen and data collection 
We thawed 2 mL of previously collected frozen human stool over ice, then added it to a 
15ml conical tube containing 3 ml of pre-reduced PBS inside of a COY anaerobic 
chamber and vortexed for 1 minute. 4-8 week-old germ-free C57BL/6 female mice were 
fasted overnight then removed from germ-free isolators and gavaged with 300 uL of 
prepared donor material. Fasting blood glucose measurements were taken with a cheek 
bleed using a StatStrip Xpress glucometer, and mice were ear punched for identification. 
Mice were subsequently placed in cages with Sani-chips™and Crink-l'Nest™ bedding, 
which have been autoclaved at 128C for 30 minutes with a 15 minute dry cycle, and with 
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nanopure drinking water which had been autoclaved in 1L pyrex bottles at 121⁰ for 2 
hours. Prior to experiment start, mice were fed a standard autoclaved chow (LabDiet 
5K67), and immediately after humanization, mice were placed on irradiated LabDiet 
5061 or Harlan TD.86489. Cages were sealed and place into an Arrowmight Maxi Seal 
IVC System, housed within a germ-free facility. Cages were changed, mice and chow 
were weighed, and pellets were collected every two weeks using sterile handling methods 
throughout the duration of the study. At study endpoints, mice body composition analysis 
was performed as previously described (Schafer et al., 2016), mice were fasted overnight, 
then euthanized using CO2 asphyxiation. Heart blood was collected immediately post-
euthanasia for fasting blood glucose tests. 
 
Histology 
The duodenum was collected into 10 mL 10% formalin and sent to the UMN 
Comparative Pathology Shared Resource, where after 24 hours, the tissue was transferred 
to 70% ethanol. 4 µm formalin-fixed, paraffin-embedded sections of tissue were 
deparaffinized and rehydrated, followed by Hematoxylin and Eosin staining. Images were 
taken using a NIKON Eclipse E 800M microscope with 10x objective, and measurements 
were made using the NIS Basic Program. 
 
Cell isolation, staining and flow cytometry 
A two-inch section of the jejunum was collected in 3% PFA, and the remainder of the 
small intestine was emptied of its contents and stored in 35 mL of CMF. Tubes were 
stored in ice during transport. Leucocyte isolation from small intestine was performed as 
previously described (Thompson et al., 2016). Briefly, for isolation of intra-epithelial 
lymphocytes (IELs) from small intestine, fecal contents were removed, and Peyer’s 
patches were excised and the gut was cut longitudinally and then into 1 cm pieces. 
Intestine pieces were incubated in 10% 1X HBSS/HEPES bicarbonate containing 15.4 
mg/100 ml dithioerythritol (30 min at 37°C, 450 rpm) to extract IEL. After separating 
IELs, gut pieces were treated further with 100 U/ml type I collagenase (Worthington 
Biochemical, Lakewood, NJ, USA) for lamina propria lymphocyte (LPL) isolation. 
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Single cell suspensions were surface-stained with antibodies to detect various leukocyte 
populations in gut. The stained samples were acquired using LSR Fortessa flow 
cytometer (BD) and analyzed with FlowJo software (Treestar). 
  
Other limitations 
Although this study will provide a cross-sectional perspective of the change in gut 
microbiomes before, immediately after, and long after migration, it is important to note 
that not all subjects recruited will have followed the same migration path. For example, 
the large wave of Hmong who arrived to the U.S. approximately 10-15 years ago are 
primarily from Wat Tham Krabok, a temple that became home to over 30,000 Hmong 
refugees after the last official Hmong refugee camp was closed in Thailand in 1992. This 
large refuge has since been closed and evacuated, therefore making it infeasible for us to 
collect representative pre-immigration samples for this group. We mitigate this by 
sampling from a rural Hmong village in northern Thailand, where resources are limited 
and living conditions are more similar to this refuge than an urban community.  
 
Results 
 
Assembly of a multi-generational Asian American immigrant cohort 
We recruited 514 healthy Hmong and Karen female individuals (aged 18-78, see 
Methods for full exclusion criteria) who either (1) were living in Thailand (HmongThai, 
KarenThai; n = 179), (2) were born in Southeast Asia and had moved to the U.S. 
(Hmong1st, Karen1st; n = 281), or (3) were born in the U.S. and whose parents were born 
in Southeast Asia (Hmong2nd; n = 54) (Figure 4.4.1A). We also recruited healthy 
Caucasian American female individuals to serve as U.S. controls (Controls; n = 36) 
(Figure 4.4.1A). We restricted the study population to females because the majority of 
recently arrived Hmong immigrants were projected to be female. Participants in each 
sample group were recruited into lean or overweight/obese body mass index (BMI) class 
stratifications (BMI < 25 or BMI ≥ 25, respectively), with the intent of obtaining similar 
sample sizes within each group (Table 4.1). Between February 2016 and March 2017, we 
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recruited and collected samples from eligible individuals throughout the Minneapolis - St. 
Paul metropolitan area in Minnesota, and at two locations in Thailand: a rural village in 
Chiang Mai province (Khun Chang Khian), and a refugee camp in Tak province (Mae 
La) (Figure 4.S1). 
 
During face-to-face enrollment, bilingual-bicultural research team members collected 
migration and medical histories (Table 4.2), anthropometrics (weight, height, waist 
circumference), 24-hour dietary recalls, and a single stool sample. A single stool sample 
was collected for 16S rRNA and metagenomic profiling of the gut microbiome. Karen 
participants who identified themselves as having arrived in the U.S. within 2 months 
were invited to participate in a longitudinal sub-study, in which 24-hour dietary recalls 
and stool samples were collected monthly for 6 months (Figure 4.4.1A). As a result, we 
enrolled 19 individuals with longitudinal samples over their first 6 to 9 months of 
residency in the U.S.. This group included 6 individuals whose initial samples were 
collected in a refugee camp in Thailand prior to relocation. As a result of our recruitment 
efforts, we collected a total of 673 stool samples comprised of 531 single and 142 
multiple time point collections. Because we stratified recruitment by a BMI threshold of 
25, examining the ratio of obese (BMI ≥ 30) to overweight (BMI between 25 and 29.9) 
individuals provides a conservative estimate of the prevalence of obesity across groups. 
Consistent with the previously observed high rate of obesity in U.S. immigrants (see 
Introduction), we see that obesity prevalence increases after a decade in the U.S. (Figure 
4.4.1B). 
 
To understand whether or not the observed changes in the gut were driven by dietary 
intake, we collected 24-hour dietary recalls from all participants, and analyzed 
macronutrient content using the United States Department of Agriculture (USDA) 
SuperTracker food record system (Britten, 2013). A total of 224 unique foods were not 
found in the SuperTracker food database, hence additional information was supplemented 
from the more comprehensive USDA Food Composition Databases (United States 
Department of Agriculture Agricultural Research Service) and published literature. We 
 52 
considered the relatedness of individual foods when assessing the similarity of dietary 
profiles across individuals. This approach relied on a hierarchical format of unique food 
codes that were derived from the USDA’s Food Nutrient and Database for Dietary 
Studies (FNDDS). These hierarchical food codes allowed individual foods to be 
categorized into a phenetic tree format where more closely related foods are grouped 
together (Figure 4.4.1C). These groupings then allowed us to share statistical strength 
across closely related foods to complement dietary analysis of macronutrients, much in 
the way that phylogenetic beta diversity analysis complements taxonomy-based profiles 
of microbiomes. Foods reported by participants that were not found in any USDA 
database (n = 72, Table 4.3) were manually assigned new food codes and inserted into the 
hierarchical food taxonomy, allowing us to account for all foods reported by all 
participants. Using this hierarchical food tree, we observe a stark difference in the overall 
variety of foods eaten by Hmong in Thailand and second-generation Hmong, despite 
similar group sample sizes and age range (Figure 4.4.1C).  
 
U.S. immigration is associated with loss of gut microbes 
We performed amplicon-based sequencing of the 16S rRNA gene V4 region on 550 stool 
samples (one sample per participant). Principal coordinate analysis (PCoA) of 
unweighted UniFrac (Lozupone et al., 2011) distances reveal that Hmong and Karen 
ethnic groups harbor distinct microbial gut compositions regardless of country of 
residence, yet their microbiomes converge toward Caucasian American microbiomes 
after relocating to the U.S. The first two principal coordinate axes show that second-
generation Hmong and Caucasian American microbiomes share nearly identical cluster 
centroids (Figure 4.4.2A), although Caucasian American microbiomes have lower inter-
individual variation. We also find that both diversity and richness is highest in 
microbiomes from the groups in Thailand and decreases with generations in the U.S. 
(Figure 4.4.2B). As with other studies (Sze and Schloss, 2016; Turnbaugh and Gordon, 
2009), we found that lower phylogenetic richness is associated with obesity across all of 
our groups, yet the median richness of obese individuals in Thailand is still higher than 
the median richness of any lean group in the U.S. (Figure 4.4.2B). These trends persist 
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after stratification by ethnicity (Figure 4.S2). These findings suggest that both obesity and 
residency in the U.S. are independently associated with loss of gut biodiversity. 
Furthermore, we observed a dramatic and systematic loss of native bacterial operational 
taxonomic units (OTUs) among first-generation Hmong (Figure 4.4.2C). Although 7 of 
the 10 most prevalent OTUs found in HmongThai are also found at similar levels in 
Hmong1st, others such as otu1812 (Faecalibacterium prausnitzii) incur a 45% loss in 
prevalence (Fisher’s exact test, FDR-corrected q = 3.05E-14) (Table 4.4). We found 28 
OTUs (10.5% of all OTUs in 75% of HmongThai) that incurred more than a 50% loss in 
prevalence among first-generation Hmong, and more than half of them belong to the 
Prevotella genus (Table 4.4).  
 
Bacteroides strains displace Prevotella strains across generations in the U.S. 
The severe loss of overall biodiversity and native bacterial members in first-generation 
immigrants is caused by a profound taxonomic shift in the gut microbiome. We examined 
the Western-associated Bacteroides and non-Western-associated Prevotella and found a 
displacement of Prevotella with Bacteroides across generations in the U.S. (Figure 
4.4.3A). Not surprisingly, the ratio of Bacteroides to Prevotella is lowest in Thailand-
resident individuals, and highest in U.S.-born Caucasian Controls. The ratio of 
Bacteroides to Prevotella in first-generation Karen, first-generation Hmong, and second-
generation Hmong increase in a stepwise fashion. This progression corresponds with the 
time that these groups have spent in the U.S. 
 
Using deep shotgun metagenomics on 55 samples (mean 22,406,875 reads/sample) from 
Hmong in Thailand, newly arrived Karen, long-term resident Hmong (who lived in the 
U.S. for more than 30 years), and Controls, we profiled strain-level variation in 
Bacteroides and Prevotella. We aligned shotgun metagenomic sequences against a 
custom database that included 256 Bacteroides genomes and 153 Prevotella genomes. To 
minimize spurious genome alignments, we profiled only Bacteroides and Prevotella 
strains with a minimum genome coverage of 50% within at least one sample. We found 
that U.S. Controls have varied Bacteroides strain profiles, and those with Prevotella tend 
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to be limited to a single strain of P. coprii (Figure 4.4.3B). Conversely, Thailand-based 
individuals carry up to 4 strains of Prevotella, with low abundances and generally low 
genomic coverage of Bacteroides strains. There may be limited characterization of 
Bacteroides strains specific to Thailand residents available in the current reference 
genome databases, which could cause us to observe lower coverage of Bacteroides strains 
in those subjects. Long-term U.S.-resident Hmong displayed an intermediate profile, 
carrying a variety of Bacteroides strains and, in several individuals, multiple Prevotella 
strains. Our findings suggest that the increase in Bacteroides after moving to the U.S. is 
driven by both an expansion of pre-existing low-abundance strains, as there is diverse 
Bacteroides strain prevalence within the Thai-resident groups, and the acquisition of new 
U.S.-based strains shared with Control subjects. 
 
U.S. immigrants lose enzymes associated with plant fiber degradation 
We also profiled microbial functional pathways in our shotgun metagenomics samples 
(Abubucker et al., 2012) (Figure 4.S3A). In long-term-resident first-generation Hmong, 
we observed increases in relative abundances in sucrose degradation, glycerol 
degradation, glucose/xylose degradation, and glucose fermentation to lactate, suggesting 
that Hmong who have lived in the U.S. more than 30 years may consume more sugary 
foods. In Hmong in Thailand, we found an enrichment of pathways relating to the 
degradation of complex carbohydrates, which includes mannose biosynthesis, mannan 
degradation, and starch degradation (Flint et al., 2012). In order to better understand the 
potential substrates degraded by these pathways lost in U.S. immigrants, we assembled 
the deep shotgun metagenomic data into scaffolds (insert metaquast results), and 
annotated carbohydrate-degrading enzymes (CAZymes) (Lombard et al., 2014; Yin et al., 
2012), and found that observed shifts in strain-level composition and functional pathways 
were accompanied by significant shifts in several types of CAZymes. We observed 
differential abundance of 58 CAZymes across the HmongThai, Hmong1st, and Control 
groups (Mann Whitney U, FDR q < 0.05, Figure 4.4.3C). These shifts included three 
beta-glucan-targeting glycoside hydrolases (GH17, GH64, GH87) that were almost 
completely lost from the Thailand-based group to the U.S.-based groups. This loss could 
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be associated with decreased ability of the microbiota to degrade certain dietary fibers. A 
loss of GH5 and GH26 glycoside hydrolases from HmongThai to Hmong1st and U.S. 
controls indicates a loss of cellulose, beta-mannan and possible xyloglucan degradative 
potential. Beta-mannan is produced by fungi as part of the cell wall, suggesting a lower 
load of fungal gut microbiota in post-immigration individuals (Engel et al., 2012). 
Cellulose and xyloglucan are plant cell-wall components, so the loss of glycoside 
hydrolases for degrading these is another indication that the microbiota of post-
immigration individuals have lost some of their ability to degrade plant fibers (El 
Kaoutari et al., 2013). 
 
Dietary acculturation partly explains microbiome acculturation 
Across sample groups, we observed significant differences in the consumption of 
macronutrients commonly associated with a Western diet: sugars, fats, and protein. We 
find that consumption of sugars and fats are associated most significantly with residency 
in the U.S., and that protein consumption is highest among first- and second-generation 
Hmong (Figure 4.4A, Figure 4.S4). These findings suggest that new arrivals may have a 
higher preference towards high-sugar, high-fat foods, such as processed snacks, and that 
it takes longer to acculturate to eating a high-protein diet. Interestingly, total calorie 
consumption is similarly high among Karen in Thailand and U.S.-based Controls (Figure 
4.4A).  
 
Our use of a hierarchical food tree enabled approximate comparisons of common 
American foods to non-American foods, and as a result, to apply tree-based ecological 
analysis methods to the diet profiles of all subjects. PCoA of unweighted UniFrac 
(Lozupone et al., 2011) of interindividual dietary intake distances reveal distinct 
separation by sample group, and a gradient of increasing dietary acculturation along the 
first principal coordinate (Figure 4.4B). Shifts toward positive values of the first principal 
coordinate are driven by decreased consumption of rice, cooked and raw vegetables, and 
fish, and increased consumption of fruits, milk, coffee, breads, pastas, soft drinks and 
juices, processed meats, cookies, carrots, roasted beef products, and chicken (Table 4.6). 
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First- and second-generation Hmong shared similar food choices (Figure 4.4B) when 
considering hierarchical relationships of foods, which cannot be determined with 
macronutrients alone; these diet-based clusters are notably different from the groupings 
seen in the microbiome-based PCoA, where second-generation Hmong instead clustered 
closely with Controls. 
 
A bipartite network of participants and their food choices show how most individual food 
choices are shared between groups (Figure 4.S5A). Sample groups are difficult to 
delineate because of the high degree of shared foods reported across all Hmong and 
Karen groups. Similar to PCoA based on food distances, we see strong overlap between 
KarenThai and Karen1st food choices, and observe highly individualized diets in 
Controls, where several participants consumed multiple foods not reported by anyone 
else in the study. Interestingly, the vast majority of diet records from Hmong and Karen 
included white rice (572 out of 630, 90.7%), compared to only 4 of the 36 Controls 
(11.1%) (Figure 4.S5B).  
 
To understand the relationship between diet and microbiome compositions, we performed 
a permutation-based Procrustes analysis to compare distances between unweighted 
UniFrac diet and microbiome distance matrices and found strong similarity between 
variation in diets and microbiomes (P=0.001, n=999 permutations) (Figure 4.S6A). We 
validated this association by comparing per-sample Procrustes distances of the original 
distance matrices against per-sample Procrustes distances of permuted distance matrices, 
and found that the original matrices are more similar (P = 1e-10) (Figure 4.S6B). These 
Procrustes tests demonstrate that similarity of microbiome-based distances and food-
based distances is significantly better than random chance. However, constrained 
ordination of the microbiome by the first 5 principal coordinates of the diet-based PCoA 
revealed that dietary variation alone explained only a fraction (16.8%) of the total 
microbiome variation (Figure 4.4C). Altogether, we find that although both microbiome 
and dietary acculturation increases with time in the U.S., diet is not the sole contributor to 
the observed gut microbiome changes in our cohort. 
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Gut biodiversity decreases according to duration of residence in the U.S. 
In a PCoA with unweighted Unifrac microbiome-based distances, we find that time spent 
in the U.S. is significantly correlated with changes seen along the first principal 
coordinate (Figure 4.5A). Conversely, gut biodiversity, as measured by Faith’s 
Phylogenetic Diversity, is negatively correlated with PC1 (Figure 4.5B). To understand 
the relationship between diversity and time in the U.S., we stratified our analysis by 
ethnic group to account for the distinct time frames of Hmong and Karen immigration 
(over 40 years versus 10 years). We found that gut biodiversity in first-generation Hmong 
significantly decreases with time in the U.S. (Figure 4.5C), while 
controlling for BMI. Further stratification by BMI class reveals similar trends of negative 
associations, but were not significant (data not shown). We also find a weak association 
between gut biodiversity and time spent in the U.S. in first-generation Karen (Figure 
4.5C), which suggests that observable changes in biodiversity may take place after 10 
years. We acknowledge that lifestyle differences between Hmong and Karen may also be 
contributing factors. 
 
Prevotella displacement continues for more than one decade 
Over time in the U.S., first-generation gut microbiome compositions diverge from their 
Thai counterparts and converge toward Caucasian Controls (Figure 4.6A). Loss of 
biodiversity impacts beta diversity, but our findings suggest that the contributions vary 
with ethnic group and timeframe. Instead, we find that the shifts in bacterial composition 
are largely governed by the displacement of Prevotella with Bacteroides. We observe a 
highly significant and strong association of time spent in the U.S. with the ratio of 
Bacteroides to Prevotella (Figure 4.6B), and these significant associations persist after 
stratification by ethnicity and within the shorter time frame of first-generation Karen 
(Figure 4.6B inset). These findings show that changes to the dominant members of the 
gut microbiome begin during the first decade of U.S. residence, and continue for longer 
than a decade. 
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Microbiome Westernization begins within 9 months after immigration 
To understand whether changes in the gut microbiome can be detected immediately after 
relocation to the U.S., we examined the gut microbiomes of 19 newly arrived Karen in a 
longitudinal cohort. PCoA of the unweighted UniFrac distances of first and last month 
stool samples show that within six months, we can detect a significant shift in microbial 
composition along the first principal coordinate (Figure 4.S7). We also found that within 
this short time frame, all but one participant gained weight (Figure 4.7A), although 
weight gain after relocation is expected in Southeast Asian refugees (Careyva et al., 
2015). We previously reported that protein consumption was similar between Karen in 
Thailand and first-generation Karen in the larger cross-sectional study (Figure 4.S4), but 
characterizing diets longitudinally allowed us to detect a subtle but significant increase in 
protein consumption after 6 months in the U.S. (Figure 4.7B). We also previously 
reported that Hmong in Thailand consume a limited variety of foods compared with 
second-generation Hmong (Figure 4.4.1C), which suggests that living in the U.S. may 
increase exposure to or encourage consumption of diverse foods. Instead, we found that 
longitudinal Karen participants reported eating fewer kinds of foods after 6 months 
(Figure 4.7C), which indicates that it may take a longer than half a year to acclimate to 
foods available in the U.S. Within this short time frame, once again we observe the 
displacement of Prevotella by Bacteroides (Figure 4.7D), indicating that microbiome 
westernization begins immediately after arrival to the U.S. Using deep shotgun 
metagenomics with 13 samples from 6 participants, we find that Prevotella and 
Bacteroides strain profiles remain largely stable over 6 months but can sometimes result 
in drastic changes (subject highlighted in blue, Figure 4.7D). 
 
Our longitudinal sub-study includes six participants with baseline characterizations of 
their gut microbiomes prior to relocation to the U.S. (Figure 4.7F). While we found 
examples of disruption to the gut immediately after arrival (ID.273 and ID.304), we 
observed that physically relocating to the U.S. induces wide variation in gut microbial 
responses, including expansion of opportunistic pathogens (ID.305), gut disruption 
several months after arrival (ID.275), and stability (ID.274, ID.308) (Figure 4.7F). 
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Western diet and Western microbes lead to adverse health outcomes 
In order to test whether the Westernized microbiome could induce deleterious changes in 
health, we performed fecal microbiota transplantation from study subjects into germ-free 
mice. We gavaged 4-7 week-old germ-free C57BL/6 mice (n = 38) with prepared stool 
samples from Thai- (T) or U.S.-based (U) donors (selected from HmongThai and 
Hmong2nd groups, matched on age and BMI) (Figure 4.6A). After humanization, mice 
were fed either a high-fiber (H) or low-fiber (L) diet and caged by diet-donor groups. At 
the end of 8 weeks, a subset of each group was sacrificed while remaining mice were co-
housed within their diet group for an additional 2 weeks. 
 
We performed 16s rRNA gene sequencing of collected mouse pellets and found clear 
separation of microbiomes by donor and diet at the end of the study (Figure 4.6B). The 
effect of cohousing varied depended on the diet: cohousing TL and UL resulted in an 
intermediate microbiome that resembled both groups, whereas cohousing TH and UH 
shifted both microbiomes towards the UH group.  
 
We found that although low-fiber groups consistently consumed less chow throughout 
the study (Figure 4.S5), this behavior was due to their increased efficiency in 
metabolizing the low-fiber diet into energy (P=3.2e-05) (Figure 4.6C). As a result, the 
low-fiber groups exhibited increased adiposity (Figure 4.6D) and elevated blood glucose 
responses (P=0.013 and P=0.012, respectively) (Figure 4.6E). Examination of the ileal 
intraepithelial compartments revealed a donor-dependent response. We found an 
elevation of inflammatory cell subtypes, TCRγδ and CD8ααTCRαβ, in US-donor groups 
(P=0.035 and P=0.027, respectively) and observed lower levels of CD4TCRαβ in Thai-
donor groups (P=0.016) (Figure 4.6F).  
 
Discussion 
This study represents the first large cohort study of the effects of migration from a non-
Western country to a Western country on the gut microbiome. Leveraging both cross-
sectional and longitudinal cohorts of immigrants and refugees, including pre-
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immigration, first-generation immigrant, and second-generation immigrant individuals, 
allowed an unprecedented examination of microbiome resilience and response to 
migration to the U.S. In these cohorts, we observed that gut microbiome diversity, 
function, and strain composition are severely impacted by migration and that both short-
term and long-term U.S. residence as well as being born in the U.S. shifts an individual's 
microbiome along an axis toward a Westernized state. 
 
We found that U.S. immigration is associated with a loss of gut microbiome diversity. 
Diversity continues to decrease for at least a decade with time spent in the U.S., and is 
further decreased in second-generation individuals born in the U.S. We also found that 
U.S. immigrants undergo a marked loss of native gut microbiota strains, and begin 
exchanging dominant strains of Prevotella for dominant strains of Bacteroides within the 
first 9 months of arrival. This demonstrates that even a short period of residence in the 
U.S. is sufficient to induce pronounced increases, in most cases over 10-fold, in the ratio 
of Bacteroides to Prevotella. Our analysis using deep shotgun metagenomics 
demonstrated that this shift was largely due to changes in the relative abundance of extant 
strains in the immigrant gut microbiome rather than total novel strain acquisition. Beta 
diversity analysis showed that the trans-generational effects of immigration are large 
enough that, within one generation in the U.S., immigrant gut microbiomes become 
nearly indistinguishable from those of the Caucasian Controls. Metagenome assembly 
and functional annotation showed that the observed changes in bacterial strains were 
associated with dramatic post-immigration shifts in the profile of carbohydrate-active 
enzymes dominant in the gut microbiota, including a near-complete loss of certain beta-
glucanases that may indicate loss of ability to break down specific dietary fibers. 
 
In addition to studying immigrant microbiomes, we also performed extensive analysis 
and modeling of differences in dietary intake, as diet is known to be a strong driver of 
microbiome variation (Bokulich et al., 2016; David et al., 2014; Muegge et al., 2011). In 
the 24-hour diet recall data, we observed clear patterns of dietary acculturation through 
analysis of macronutrients as well as food choices. While we also observed a similar 
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trend of Westernization in microbiome and in dietary choices, we found that only a small 
amount of microbiome variation (16.8%) (Figure 4.S4C) in the microbiome is explained 
by diet.  
 
Using humanized germ-free mice, we found that a Western-associated microbiome 
induces inflammation that may be deleterious to long-term health. Using flow cytometry 
to characterize immune cell populations in the gut intra-epithelial lymphocytes we found 
that the Westernized post-immigration microbiome stimulates increased inflammatory 
responses. This includes elevated TCRγδ in mice receiving post-immigration donor 
microbiomes. Elevated TCRγδ levels have been found to exhibit cytotoxic properties and 
produce inflammatory cytokines (Olivares-Villagómez and Van Kaer, 2018), and TCRγδ 
has been elevated in models of colitis, environmental enteropathy, and celiac disease 
(Abadie et al., 2012; Brown et al., 2015; Tsuchiya et al., 2003). CD4TCRαβ cells were 
elevated in Thai donor microbiome groups, which has been found to secrete IFNγ, a 
cytokine important for clearing pathogenic bacteria from the gut (Hess et al., 1996). 
Contradicting reported TCRγδ levels, we found that CD8ααTCRαβ, considered 
immunoregulatory and protective against colitis (Denning et al., 2007; Poussier et al., 
2002), was significantly elevated in US donor microbiome groups. The levels of TCRγδ 
found at several orders of magnitude higher than its regulatory counterparts suggests a 
predominantly inflammatory intestinal environment. Although we do not observe 
differential inflammatory responses due to diet, we acknowledge that diet also has the 
potential to mediate the gut microbiome in order to induce low-grade inflammation (Cani 
et al., 2008, 2009a). 
 
This study has several limitations. The fact that dietary acculturation only explains a 
small amount of microbiome variation suggests that immigration-induced microbiome 
changes are driven by a combination of diet and other, probably complex, factors 
associated with adjustment to life in the U.S. Most of these factors are challenging to 
examine in the context of this study. These include changes in exposure to stress, 
exercise, chlorinated municipal drinking water, antibiotics, and treatment for gut 
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parasites. There is likely to be an interacting web of altered exposures due to the dramatic 
shift in lifestyle following immigration to the U.S. that affect gut microbiome taxonomy, 
function, and diversity. In addition, although we have a large cross-sectional study 
population and a unique subset with longitudinal samples, our study design does not 
allow us to test what factors associated with U.S. immigration are causing loss of 
microbiome function and diversity, nor whether the changes in microbiome are 
contributing to the high incidence of obesity in U.S. immigrants. 
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Chapter 5: Concluding remarks and future work 
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In Chapter 2, we synthesized numerous complementary sources in this review, including 
microecological studies linking antibiotics and dysbiosis, mechanistic studies linking 
specific types of dysbiosis to specific disease outcomes, and reviews of epidemiological 
studies supporting antibiotics and increased disease risk. By synthesizing these 
independent literature reviews, we identified four major types of antibiotics-related 
dysbiosis, and we have presented a model for discussing and measuring pediatric 
dysbiosis in the context of several major diseases. Our findings indicate substantial 
existing evidence for a number of causal mechanisms by which the microbiome mediates 
antibiotic-related disease risk. The primary goal of continued research in pediatric 
dysbiosis will be to gain a mechanistic understanding how antibiotics usage by children 
may disrupt normal development of the gut microbiota, and at times consequently the 
immune system, potentially leading to increased risk of diseases like obesity, diabetes, 
allergies, asthma, and inflammatory bowel disease. Future work involving large, 
longitudinal cohorts of infants followed throughout life will be necessary in directly 
implicating microbial dysbiosis in mediating the link between childhood antibiotics and 
later development of disease.  
 
In Chapter 3, we developed MLRepo, a repository of curated microbiome datasets made 
available for the computational community, and presented several case studies for how it 
can be a valuable resource. We expect that this repository will be of important use for 
machine-learning developers unfamiliar with microbiome data, educational purposes, and 
for scientists with limited access to high performance computing resources. We also hope 
that future datasets and tasks will be submitted by other researchers, and expect our 
repository to grow. Future work to transfer the repository from GitHub to a more robust 
database solution will be necessary. 
 
In Chapter 4, we studied the impact of immigration on the gut microbiome by working 
with Hmong and Karen individuals pre-immigration, post-immigration, and who were 
born in the U.S. We demonstrated that U.S. immigration is associated with profound 
perturbations to the gut microbiome, including loss of native strain diversity, changes in 
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metabolic function, and shifts from Prevotella dominance to Bacteroides dominance. 
These changes begin immediately upon arrival and continue over decades of U.S. 
residence. The loss of diversity is compounded in obese individuals and in second-
generation individuals born in the U.S. The microbiome has been shown to play a causal 
role in obesity and diabetes in animal models. Low gut microbiome diversity has been 
associated with a wide range of metabolic, infectious, and autoimmune diseases (Al-
Ghalith et al., 2015; Chang et al., 2008; Gevers et al., 2014; Karlsson et al., 2013; Le 
Chatelier et al., 2013; Montassier et al., 2016; Turnbaugh et al., 2009b). These results 
demonstrate that further study is warranted to determine whether Westernization of the 
gut microbiome in immigrants may be contributing to their increased risk of metabolic 
diseases. In addition, the special circumstances that result in the relocation of refugees to 
the U.S. often means that these groups are especially vulnerable to socioeconomic 
disparities (Table 4.2), which may have additional direct or indirect impacts on health 
outcomes. Continued efforts to follow large, diverse, longitudinal immigrant and refugee 
cohorts, including dietary and therapeutic intervention studies, will be critical for 
determining how the microbiome may potentially be modulated to protect and improve 
immigrant metabolic health (Fu et al., 2016; Snijder et al., 2017).  
 
Broader Impacts 
 
Comprehensive assessment of microbiome structure in two minority ethnic groups 
The main work in Chapter 4 focuses on two understudied at-risk ethnic groups who make 
up a large proportion of Minnesota’s Asian population. As a community-based and 
community-participatory research project, this project has been formed with equal 
partnership of both community members and academic experts. Gut microbiome research 
in the U.S. has been primarily studied in Caucasian populations, and crowded-sourced 
projects such as the American Gut Project (McDonald et al., 2018) has self-selected for 
populations who are fluent in English, can navigate the Internet, have the means to donate 
$100, etc. This project represents an extremely unique opportunity for gut microbiome 
research to reach understudied and marginal groups, and for us to introduce and spread 
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knowledge of a relatively new and cutting-edge topic to these populations. Furthermore, 
although several studies have compared populations across countries (Yatsunenko et al., 
2012), urban to rural gradients (Morton et al., 2015; Obregon-Tito et al., 2015), and 
short-term dietary interventions (David et al., 2014; O’Keefe et al., 2015), this research 
is, to our knowledge, the first to look at gut microbiomes of populations who have 
physically and permanently relocated between drastically different environments. 
  
International project spanning migratory paths of the Hmong and Karen 
Chapter 4 also transcends international borders as we worked with Hmong and Karen 
populations in the U.S. and Thailand. Thus, this work captures a comprehensive snapshot 
of how gut microbiomes differ across a rural village, refugee camp, and time-based 
integration into westernized life in Minnesota, while controlling for gender and ethnicity. 
The health of our target rural Hmong village has been documented over the last 15 years 
(Kunstadter, 2001), therefore the addition of gut microbiome analysis will be a powerful 
complement to this existing data. In addition, this study presents an unprecedented 
opportunity to work with residents of Mae La refugee camp, which is currently the 
largest refugee camp in Thailand and home to over 50,000 individuals of whom 90% are 
ethnic Karen (Banjong et al., 2003). Since 2005, nearly 100,000 refugees from Thailand 
have been resettled in the U.S. and other western countries (U.S. Department of State, 
Bureau of Population, Refugees, and Migration), hence emphasizing the relevance of our 
work for this population. The results of this study also has important implications for 
Thailand’s Hmong-Thai and Karen-Thai residents, with potential to inform future work 
in understanding how non-communicable disease risk in these populations change with 
expansion of westernization and economic development, but also in response to in-
country migration across the rural-urban gradient. 
  
Cutting-edge tools enable novel insights into microbiome analyses 
A combination of 16s rRNA amplicon sequencing, deep shotgun metagenomic 
sequencing, and targeted metabolomics will be applied to provide a comprehensive view 
of the changing gut microbiome over space and time. The amount of total data generated 
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will be on the order of hundreds of millions of sequences, requiring cutting-edge 
computational tools and techniques to identify signals and trends. The advanced 
computational methods developed for the human research study resulted in resources 
such as MLRepo that have potential to be important resources for computational 
scientists. 
  
Potential for translatable results with impact to public health in Minnesota 
Our results have the potential to transform nutritional guidance provided by clinicians 
and to be integrated permanently into the “new immigrant” core curriculum offered at 
partnering community organizations. Additionally, refugee health practices at the 
Minnesota Department of Health may be expanded to include gut microbiome analysis in 
medical examinations of new arrivals. Worksite wellness policies for Minnesota 
companies employing large numbers of Karen or Hmong employees may also be 
impacted to promote dietary fiber consumption. And importantly, prevention of obesity 
and hence diabetes, heart disease, and other obesity-related conditions in the broader U.S. 
immigrant population has tremendous potential to reduce the high economic burden of 
obesity, an estimated $147 to $210 billion a year (Finkelstein et al., 2009). 
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Tables 
Chapter 2 Tables 
 
INFECTIOUS DISEASES 
Antibiotics and 
Disease 
 (Ayres et al., 2012; Brandl et al., 2008; Buffie et al., 2012; Croswell et 
al., 2009; Noverr et al., 2004; Sekirov et al., 2008; Ubeda et al., 2010) 
Antibiotics and 
Microbiome 
 (Ayres et al., 2012; Brandl et al., 2008; Buffie et al., 2012; Croswell et 
al., 2009; Donskey et al., 2000; Noverr et al., 2004; Sekirov et al., 2008; 
Ubeda et al., 2010) 
Microbiome 
and Disease 
 (Abt et al., 2012; Asahara et al., 2001; Buffie et al., 2012; Mai et al., 
2011b; Mazmanian et al., 2008; Shu et al., 2000; Ubeda et al., 2010; 
Wang et al., 2009) 
ALLERGY, ATOPIC, AND AUTOIMMUNE DISEASES 
Antibiotics and 
Disease 
 (Droste et al., 2000; Farooqi and Hopkin, 1998; Johnson et al., 2005; 
McKeever et al., 2002; Ong et al., 2014; Russell et al., 2012; Stefka et 
al., 2014; Wickens et al., 1999) 
Antibiotics and 
Microbiome 
 (Russell et al., 2012; Stefka et al., 2014) 
Microbiome 
and Disease 
 (Abrahamsson et al., 2012; Atarashi et al., 2013; Bisgaard et al., 2011; 
Björkstén et al., 2001b; Brown et al., 2011; Cani et al., 2008; Giongo et 
al., 2011; Kalliomäki et al., 2001; Lee and Mazmanian, 2010; Lundell et 
al., 2014; Russell et al., 2012; Sellitto et al., 2012; Sjögren et al., 2009; 
Stefka et al., 2014; Valladares et al., 2010; Wen et al., 2008) 
OBESITY 
Antibiotics and 
Disease 
 (Ajslev et al., 2011; Bailey et al., 2014; Cho et al., 2012c; Cox et al., 
2014; Trasande et al., 2013) 
Antibiotics and 
Microbiome 
 (Ajslev et al., 2011; Cho et al., 2012c; Cox et al., 2014) 
Microbiome 
and Disease 
 (Ajslev et al., 2011; Cho et al., 2012c; Cox et al., 2014; Ley et al., 2006; 
Ridaura et al., 2013; Turnbaugh et al., 2009b) 
Table 2.1. References synthesizing mechanistic and epidemiological evidence linking 
antibiotics, changes in the gut microbiome, and disease.   
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Chapter 3 Tables 
 
 
Table 3.1. Dataset descriptions 
  
Project 
Name 
V 
Region 
Target 
size 
Num 
samples 
Num 
subjects 
Area Description Sequencing 
Technology 
Study 
Design 
Cho 2012 V3 177 95 47 Antibiotics Mouse fecal and cecal 
samples, Control vs. 4 
kinds of antibiotics 
454 Cross-
Sectional 
Claesson 
2012 
V4 221 168 168 Age Elderly and young 
adults 
454 Cross-
Sectional 
David 2014 V4 282 235 11 Diet Plant-based vs. 
Animal-based diet, 
Cross-over study 
Illumina 
MiSeq 
Longitudinal 
Gevers 
2014 
V4 173 1321 668 IBD Biopsies from IBD 
patients prior to 
treatment 
Illumina 
MiSeq 
Cross-
Sectional 
HMP 2012 V35 527 6407 242 Body Habitat, 
Gender 
Up to 18 body sites 
across 242 healthy 
subjects at 1-2 time 
points 
454 Cross-
Sectional 
Kostic 2012 V35 569 190 95 Colorectal 
Cancer 
Adjacent Healthy vs. 
Tumor Colon Biopsy 
Tissues 
454 Paired 
Montassier 
2016 
V56 280 28 28 Bacteremia Patients prior to 
chemotherapy who did 
or did not develop 
bacteremia 
454 Cross-
Sectional 
Morgan 
2012 
V35 569 231 231 IBD Healthy, Crohn's 
Disease, or Ulcerative 
Colitis patients 
454 Cross-
Sectional 
Turnbaugh 
2009 
V2 230 281 154 Obesity Monozygotic or 
dizygotic twin pairs 
concordant for BMI 
class, and their 
mothers 
454 Cross-
Sectional 
Wu 2011 V12 244 95 10 Diet Controlled HighFat or 
LowFat feeding on 10 
subjects over 10 days 
454 Longitudinal 
Yatsunenko 
2012 
V4 282 531 531 Geography, 
Age, Gender 
Humans of varying 
ages from the USA, 
Malawi, and Venezuela 
Illumina 
MiSeq 
Cross-
Sectional 
Ravel 2011 V12 240 396 396 Bacterial 
Vaginosis 
Vaginal samples from 
four ethnic groups 
nugent scores for 
bacterial vaginosis 
454 Cross-
Sectional 
Karlsson 
2013 
NA NA 144 144 Diabetes Patients with normal, 
impaired, or type 2 
diabetes glucose 
tolerance categories 
Illumina HiSeq  Cross-
Sectional 
Qin 2012 NA NA 134 134 Diabetes Healthy vs type 2 
diabetes Chinese 
patients 
Illumina HiSeq  Cross-
Sectional 
Qin 2014 NA NA 130 130 Cirrhosis Cirrhosis versus 
healthy 
Illumina HiSeq  Cross-
Sectional 
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Chapter 4 Tables 
Sample Group BMI < 25 BMI ≥ 25 
KarenThai 45 39 
HmongThai 42 53 
Karen1st 77 67 
Hmong1st 52 85 
Hmong2nd 19 35 
Controls 23 13 
 
Table 4.1. Sample group recruitment stratified by BMI threshold of 25.  
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 KarenThai HmongThai Karen1st Hmong1st Hmong2nd Control P 
N 84 95 144 137 54 36  
        
Age 35 (18-55) 43 (20-78) 35 (18-67) 39 (18-65) 25 (18-39) 34 (18-64) 3.60E-16 
        
Waist-to-Height 
Ratio 
0.52  
(0.37-0.71) 
0.61  
(0.47-0.92) 
0.57  
(0.38-0.71) 
0.61  
(0.4-0.83) 
0.61  
(0.4-0.87) 
0.55  
(0.44-0.9) 
1.50E-18 
        
Years in US NA NA 3  
(0.003-9.8) 
20  
(0.049-41) 
NA NA 5.80E-40 
BMI Class       5.00E-04 
Lean 45 (53.6) 42 (44.2) 77 (53.5) 52 (38) 19 (35.2) 23 (63.9)  
Overweight 30 (35.7) 37 (38.9) 51 (35.4) 54 (39.4) 16 (29.6) 4 (11.1)  
Obese 9 (10.7) 16 (16.8) 16 (11.1) 31 (22.6) 19 (35.2) 9 (25)  
        
Alcohol Use       5.00E-04 
Never 83 (98.8) 84 (88.4) 118 (81.9) 113 (82.5) 27 (50) 5 (13.9)  
Daily 0 (0) 0 (0) 3 (2.08) 0 (0) 0 (0) 0 (0)  
Weekly 0 (0) 0 (0) 2 (1.39) 6 (4.38) 9 (16.7) 10 (27.8)  
Monthly 0 (0) 5 (5.26) 3 (2.08) 7 (5.11) 11 (20.4) 13 (36.1)  
< Monthly 0 (0) 0 (0) 12 (8.33) 10 (7.3) 6 (11.1) 7 (19.4)  
Quit 1 (1.19) 6 (6.32) 5 (3.47) 0 (0) 1 (1.85) 1 (2.78)  
        
Tobacco Use       5.00E-04 
Never 73 (86.9) 92 (96.8) 130 (90.3) 135 (98.5) 48 (88.9) 28 (77.8)  
Daily 10 (11.9) 0 (0) 8 (5.56) 1 (0.73) 1 (1.85) 0 (0)  
< Monthly 1 (1.19) 1 (1.05) 1 (0.694) 0 (0) 3 (5.56) 2 (5.56)  
Quit 0 (0) 2 (2.11) 5 (3.47) 1 (0.73) 2 (3.7) 6 (16.7)  
        
Highest Education       5.00E-04 
None 16 (19) 0 (0) 0 (0) 4 (2.92) 0 (0) 0 (0)  
ESL 0 (0) 0 (0) 96 (66.7) 14 (10.2) 0 (0) 0 (0)  
< HS 38 (45.2) 34 (35.8) 18 (12.5) 25 (18.2) 1 (1.85) 0 (0)  
HS 24 (28.6) 9 (9.47) 23 (16) 31 (22.6) 8 (14.8) 1 (2.78)  
College 2 (2.38) 4 (4.21) 0 (0) 41 (29.9) 38 (70.4) 10 (27.8)  
Graduate School 4 (4.76) 0 (0) 2 (1.39) 12 (8.76) 6 (11.1) 25 (69.4)  
        
Birth Location       5.00E-04 
Refugee Camp 6 (7.14) 2 (2.11) 32 (22.2) 31 (22.6) 0 (0) 0 (0)  
Rural 77 (91.7) 93 (97.9) 110 (76.4) 101 (73.7) 1 (1.85) 1 (2.78)  
Urban 1 (1.19) 0 (0) 2 (1.39) 3 (2.19) 53 (98.1) 34 (94.4)  
        
Medical Assistance NA NA 119 (82.6) 60 (43.8) 15 (27.8) 2 (5.56) 5.00E-04 
        
Public Housing NA NA 20 (13.9) 20 (14.6) 9 (16.7) 4 (11.1) 0.92 
        
Children Receives 
Free Lunch 
NA NA 89 (61.8) 54 (39.4) 5 (9.26) 3 (8.33) 5.00E-04 
 
 
Table 4.2. Sample Group Characteristics.  
All values are represented as mean (min - max). HS = High School; ESL = English as a 
Second Language; < = less than. Note that all participants are female, for reasons already 
noted. 
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Acacia Leaves Cha om  M 150 
Asia Mix Milk Candy 
Banana Flower Naked Green Juice 
Banana Trunk Nature Valley Peanut Butter Cup 
Banh Mi Vietnamese Pork Sandwich  Pacific Soup Sweet Potato Masala 
Beijing Beef Pad Kraprow 
Birdy Thai Coffee  Pediasure 
Chili Paste Pork Skin 
Djenkol Bean Protein Powder 
Dried Fish Soup Pumpkin Leaves 
Dried Fried Fish Raising Canes 3 box combo no drink  
Egg Noodles Yellow  Rambutan 
Ei Kyar Kway  Rambutan canned  
Ellse Roselle Leaves 
Exo Protein Bar Schaut Thee Zay Byar 
Fish Paste Sesbania 
Fish Soup Shrimp Paste 
Gourd Skinny Cow Chocolate Bar 
Green Max Yams and Multi Grain Cereal Snake Loofah 
Halawa Spinach Smoothie 
Hmong Sausage Sweet Thai Chili Sauce 
Hon Tsai Tai Tapioca 
Jack Fruit Taro Leaf 
Khao Poon  Thai Glass Noodle Salad 
Kaw Naw Thai Northern Sausage 
Khao Soy Soup Thai Papaya Salad 
Khao Pia Thai Tapioca Dessert with coconut  
Larb Moo Tomato Curry 
Lead Tree Veggie Fritters 
Lead Tree Pod Vietnamese Sausage 
Lean 25 Smoothie Voiz Cracker Milk  
Leek and Potato Soup Water Convolvulus Water Spinach  
Sin Tone Ma Nwe  Wheat Powder and Sugar 
Longan Wing Bean 
Loofah Yakult 
Luna Protein Bar 
Zesty Chicken and Black Bean Salad 
Bowl Starbucks  
 
Table 4.3. Foods that were individually researched, then entered as custom foods 
into SuperTracker and assigned a unique identifier for the food tree.  
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OTUID q diff-mean-prevalence Taxonomy 
220 6.84E-02 0.051 t__Prevotella copri DSM 18205 
553 2.05E-01 0.029 Enterobacteriaceae 
899 1.18E-01 0.036 Blautia faecis 
921 3.85E-02 0.058 Hungatella effluvii 
1175 7.26E-01 0.011 Romboutsia timonensis 
58 5.05E-01 -0.011 Faecalibacterium prausnitzii 
75 3.26E-01 0.034 Faecalibacterium prausnitzii 
12 5.70E-01 0.023 Gemmiger formicilis 
1611 2.46E-04 0.165 Clostridium 
1812 3.05E-14 0.456 Faecalibacterium prausnitzii 
267 2.76E-01 0.038 t__Prevotella copri DSM 18205 
394 6.58E-01 -0.014 t__Bacteroides vulgatus ATCC 8482 
543 7.51E-02 0.068 Enterobacterales 
818 4.04E-01 0.031 Blautia luti 
909 2.76E-01 0.038 Dorea formicigenerans 
936 5.70E-01 0.023 Blautia 
1276 1.81E-02 0.103 Faecalibacterium prausnitzii 
1667 8.13E-01 0.013 [Eubacterium] hallii 
1773 4.60E-01 0.035 Eubacterium 
1845 9.16E-06 0.224 Faecalibacterium prausnitzii 
1905 2.89E-09 0.337 Faecalibacterium prausnitzii 
455 1.39E-03 0.148 t__Parabacteroides distasonis ATCC 8503 
614 8.13E-01 0.013 Butyricicoccus 
63 1.43E-06 0.254 Faecalibacterium prausnitzii 
71 6.96E-03 0.118 Faecalibacterium prausnitzii 
754 8.13E-01 0.013 Anaerostipes hadrus 
806 6.26E-01 0.020 t__Blautia obeum ATCC 29174 
822 2.86E-02 0.096 Blautia obeum 
1643 1.64E-05 0.230 Clostridiales 
1890 9.39E-06 0.238 Faecalibacterium prausnitzii 
20 7.98E-04 0.169 Subdoligranulum variabile 
832 8.02E-01 -0.013 Fusicatenibacter saccharivorans 
884 4.00E-02 0.093 Lachnoclostridium 
1200 7.38E-02 0.091 Intestinibacter bartlettii 
1552 6.84E-01 0.029 Erysipelotrichaceae 
1888 2.45E-08 0.337 Faecalibacterium prausnitzii 
3761 2.10E-03 0.160 Blautia 
881 6.84E-01 0.021 Lachnoclostridium 
1458 2.47E-01 0.065 Clostridiales 
1453 6.86E-04 0.190 Oscillospiraceae 
3283 1.09E-03 0.182 Blautia 
427 6.49E-01 -0.021 Bacteroides 
576 3.35E-01 0.057 t__Haemophilus parainfluenzae ATCC 33392 
828 1.77E-01 0.073 Fusicatenibacter 
1809 5.48E-13 0.504 Faecalibacterium prausnitzii 
1652 5.90E-01 0.031 Lactobacillus rogosae 
1728 4.85E-01 -0.032 Roseburia faecis 
1956 5.96E-08 0.354 Faecalibacterium 
383 9.97E-03 0.149 Alistipes shahii 
43 1.19E-07 0.338 Faecalibacterium prausnitzii 
929 2.37E-02 0.125 Hungatella 
1672 5.11E-01 -0.036 [Eubacterium] hallii 
1709 8.23E-02 0.099 t__Roseburia intestinalis L1-82 
1715 4.87E-01 0.044 t__Roseburia hominis A2-183 
1846 1.21E-06 0.315 Faecalibacterium prausnitzii 
2541 1.39E-08 0.386 t__Prevotella copri DSM 18205 
285 6.20E-05 0.251 t__Prevotella copri DSM 18205 
42 1.21E-06 0.315 Faecalibacterium prausnitzii 
4334 5.96E-02 0.107 Blautia 
738 2.08E-01 -0.052 Actinomyces odontolyticus 
856 7.96E-04 0.203 Clostridiales 
886 5.38E-03 0.171 Ruminococcus 
895 2.18E-01 0.075 Lachnoclostridium 
953 6.98E-01 -0.020 Bacteroides xylanolyticus 
1283 3.04E-02 -0.080 Streptococcus 
1288 3.78E-01 -0.048 Streptococcus 
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1752 2.29E-02 0.145 t__Ruminococcus faecis JCM 15917 
930 1.28E-01 0.097 Hungatella 
1277 1.41E-01 0.094 Faecalibacterium prausnitzii 
3910 2.55E-01 0.078 Blautia 
4372 7.98E-04 0.225 Faecalibacterium prausnitzii 
743 5.43E-02 0.127 Tyzzerella 
771 3.33E-01 0.070 Lachnoclostridium 
1045 6.51E-01 0.034 Collinsella aerofaciens 
1084 5.45E-01 0.042 Collinsella aerofaciens 
1595 3.05E-02 0.150 Phascolarctobacterium succinatutens 
1463 1.54E-01 0.100 Oscillibacter 
1786 3.08E-02 0.141 Eubacterium 
2346 4.46E-08 0.397 t__Prevotella copri DSM 18205 
3924 2.70E-01 0.075 Blautia 
435 2.04E-01 -0.065 t__Bacteroides xylanisolvens XB1A 
534 1.54E-01 0.092 Desulfovibrio 
9 1.71E-09 0.447 Gemmiger formicilis 
928 8.23E-02 0.117 Hespellia 
1863 3.11E-03 0.206 Faecalibacterium prausnitzii 
1986 9.06E-09 0.432 Faecalibacterium prausnitzii 
2571 5.00E-10 0.474 t__Prevotella copri DSM 18205 
664 4.53E-01 0.056 Acutalibacter 
954 5.54E-01 0.048 Bacteroides xylanolyticus 
962 9.15E-01 0.014 Coprococcus catus 
1252 1.37E-04 0.281 Gemmiger formicilis 
1452 8.03E-05 0.290 Oscillibacter 
1523 8.44E-03 0.188 Holdemanella biformis 
23 6.26E-01 -0.040 Faecalibacterium 
1922 2.84E-06 0.349 Faecalibacterium prausnitzii 
1957 8.55E-07 0.374 Faecalibacterium 
1971 1.86E-02 0.171 Faecalibacterium 
2569 6.34E-11 0.510 t__Prevotella copri DSM 18205 
411 6.26E-01 -0.040 Bacteroides uniformis 
4326 8.44E-03 0.188 t__[Eubacterium rectale] ATCC 33656 
940 3.77E-01 0.070 Blautia 
95 8.03E-05 0.290 Faecalibacterium prausnitzii 
1660 4.17E-02 0.152 t__[Eubacterium] eligens ATCC 27750 
1725 6.45E-03 0.204 t__[Eubacterium rectale] ATCC 33656 
1891 1.66E-04 0.281 Faecalibacterium prausnitzii 
2337 8.84E-08 0.418 t__Prevotella copri DSM 18205 
283 1.26E-08 0.452 t__Prevotella copri DSM 18205 
3963 3.89E-01 0.067 Blautia 
4830 3.38E-07 0.392 [Eubacterium] hallii 
4880 3.29E-05 0.315 t__[Eubacterium rectale] ATCC 33656 
503 1.86E-01 0.101 t__Parabacteroides merdae ATCC 43184 
798 5.77E-02 0.144 Ruminococcus faecis 
905 1.05E-01 0.118 Clostridiales 
1206 2.04E-07 0.411 Terrisporobacter petrolearius 
1402 3.24E-01 0.081 Veillonella 
1688 3.32E-02 0.159 t__Senegalimassilia anaerobia JC110 
1939 1.19E-07 0.419 Faecalibacterium prausnitzii 
1951 1.19E-07 0.419 Faecalibacterium prausnitzii 
1984 7.01E-14 0.619 Faecalibacterium prausnitzii 
2325 3.68E-11 0.541 t__Prevotella copri DSM 18205 
255 8.23E-02 0.133 t__Prevotella copri DSM 18205 
3282 7.13E-11 0.532 Dorea longicatena 
3760 4.38E-06 0.359 Dorea longicatena 
4134 7.36E-03 0.203 Collinsella aerofaciens 
4786 1.29E-05 0.341 Lactobacillus rogosae 
773 6.59E-01 -0.031 Lachnoclostridium 
918 6.84E-01 0.038 Blautia obeum 
1033 2.66E-01 0.087 Collinsella aerofaciens 
1086 5.53E-01 -0.045 Collinsella aerofaciens 
1217 1.21E-02 0.201 Sutterella 
1442 5.88E-04 0.271 Clostridium 
2031 1.38E-04 0.307 Faecalibacterium prausnitzii 
208 1.64E-06 0.386 t__Prevotella copri DSM 18205 
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2106 9.05E-06 0.359 Faecalibacterium prausnitzii 
248 1.83E-08 0.465 t__Prevotella copri DSM 18205 
2513 1.22E-07 0.429 t__Prevotella copri DSM 18205 
2545 1.08E-09 0.508 t__Prevotella copri DSM 18205 
2788 3.05E-14 0.640 t__Prevotella copri DSM 18205 
3285 1.46E-04 0.298 Collinsella aerofaciens 
3773 1.46E-04 0.298 Faecalibacterium prausnitzii 
3929 4.88E-02 0.157 Blautia 
3959 9.07E-04 0.263 Blautia 
4112 1.22E-07 0.429 Collinsella aerofaciens 
809 5.53E-03 0.219 [Clostridium] glycyrrhizinilyticum 
917 1.18E-01 0.122 Clostridiales 
1078 4.24E-01 0.067 Collinsella aerofaciens 
1085 9.26E-01 -0.013 Collinsella aerofaciens 
1849 3.35E-12 0.591 Faecalibacterium prausnitzii 
227 2.16E-06 0.387 t__Prevotella copri DSM 18205 
2349 1.21E-16 0.707 t__Prevotella copri DSM 18205 
2462 4.25E-08 0.458 t__Prevotella copri DSM 18205 
302 4.25E-08 0.458 t__Prevotella copri DSM 18205 
400 4.48E-01 -0.058 Bacteroides dorei 
437 5.57E-01 -0.049 Bacteroides ovatus 
4371 3.16E-10 0.529 Faecalibacterium prausnitzii 
69 4.55E-04 0.280 Faecalibacterium prausnitzii 
938 9.26E-01 0.013 Blautia 
1332 9.97E-02 0.135 Flintibacter 
1466 5.59E-02 0.162 Oscillibacter 
1813 1.28E-06 0.406 Faecalibacterium prausnitzii 
1909 5.12E-11 0.568 Faecalibacterium prausnitzii 
1987 9.78E-08 0.451 Faecalibacterium prausnitzii 
202 2.46E-08 0.478 t__Prevotella copri DSM 18205 
2121 1.77E-04 0.316 Faecalibacterium prausnitzii 
2345 7.08E-14 0.649 t__Prevotella copri DSM 18205 
2348 1.11E-15 0.694 t__Prevotella copri DSM 18205 
2459 1.20E-05 0.370 t__Prevotella copri DSM 18205 
2810 1.23E-17 0.739 t__Prevotella copri DSM 18205 
4060 6.86E-09 0.496 Clostridiales 
450 6.70E-03 0.226 t__Parabacteroides distasonis ATCC 8503 
4496 2.01E-12 0.604 Clostridiales 
524 1.30E-05 0.361 t__Prevotella copri DSM 18205 
1178 5.01E-03 0.243 Romboutsia timonensis 
1072 3.61E-01 0.088 Collinsella aerofaciens 
1461 1.04E-01 0.142 Oscillospiraceae 
1616 5.92E-02 0.161 Clostridium 
1767 9.26E-01 -0.013 Blautia 
1870 5.94E-11 0.571 Faecalibacterium prausnitzii 
1970 5.68E-04 0.288 Faecalibacterium 
201 8.87E-09 0.498 t__Prevotella copri DSM 18205 
221 4.72E-06 0.389 t__Prevotella copri DSM 18205 
2354 2.81E-06 0.398 t__Prevotella copri DSM 18205 
2465 1.88E-07 0.453 t__Prevotella copri DSM 18205 
2653 2.81E-06 0.398 t__Prevotella copri DSM 18205 
2705 3.19E-11 0.580 t__Prevotella copri DSM 18205 
3840 7.86E-02 0.151 Dorea longicatena 
3876 4.40E-02 0.170 Dorea formicigenerans 
4115 7.86E-02 0.151 Collinsella aerofaciens 
666 9.26E-01 0.015 Ruminococcus bromii 
758 7.10E-01 0.042 Ihubacter 
1076 8.18E-01 0.029 Collinsella aerofaciens 
1146 3.69E-01 0.085 Thermoactinomycetaceae 
1548 6.29E-02 0.159 Turicibacter sanguinis 
1597 2.81E-06 0.408 Phascolarctobacterium succinatutens 
1766 3.02E-11 0.593 Coprococcus 
1819 8.53E-09 0.510 Gemmiger formicilis 
1835 4.88E-05 0.353 Faecalibacterium prausnitzii 
1883 4.88E-06 0.399 Faecalibacterium prausnitzii 
1999 8.23E-02 0.149 Faecalibacterium prausnitzii 
2071 2.81E-06 0.408 Faecalibacterium prausnitzii 
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2338 1.71E-09 0.538 t__Prevotella copri DSM 18205 
4146 4.48E-01 0.075 Collinsella aerofaciens 
432 8.13E-01 -0.026 Bacteroides fragilis 
4328 1.44E-03 0.279 t__Ruminococcus faecis JCM 15917 
4911 1.38E-04 0.334 Faecalibacterium prausnitzii 
52 1.19E-07 0.464 Faecalibacterium prausnitzii 
5389 3.10E-08 0.491 Faecalibacterium prausnitzii 
848 4.60E-02 0.177 Dorea longicatena 
949 6.29E-02 0.159 Hungatella 
1049 8.19E-01 0.025 Collinsella aerofaciens 
1145 6.00E-03 0.241 Thermoactinomycetaceae 
1123 1.53E-04 0.335 Blautia faecis 
1262 6.00E-03 0.241 Parasutterella excrementihominis 
1771 4.88E-02 0.175 t__[Eubacterium rectale] ATCC 33656 
1848 3.02E-05 0.372 Faecalibacterium prausnitzii 
1916 9.99E-06 0.391 Faecalibacterium prausnitzii 
1928 6.64E-08 0.485 Faecalibacterium prausnitzii 
1950 2.46E-04 0.325 Faecalibacterium prausnitzii 
2009 1.81E-02 0.213 Faecalibacterium prausnitzii 
3554 3.02E-05 0.372 t__[Eubacterium rectale] ATCC 33656 
3950 1.13E-01 0.147 Blautia 
4136 2.46E-04 0.325 Collinsella aerofaciens 
4151 3.61E-02 0.185 Collinsella aerofaciens 
4327 9.99E-06 0.391 Roseburia faecis 
4439 2.93E-06 0.419 Faecalibacterium prausnitzii 
6447 6.64E-08 0.485 Subdoligranulum variabile 
14 4.55E-04 0.316 Gemmiger formicilis 
1467 7.04E-04 0.307 Oscillibacter 
1473 1.81E-03 0.278 Sporobacter 
2081 9.84E-07 0.449 Faecalibacterium prausnitzii 
219 5.02E-07 0.459 t__Prevotella copri DSM 18205 
2317 2.48E-09 0.544 Blautia 
2406 1.61E-12 0.649 t__Prevotella copri DSM 18205 
3626 3.34E-06 0.421 Lactobacillus rogosae 
3820 4.59E-01 0.079 Fusicatenibacter saccharivorans 
3884 2.72E-02 0.202 Hungatella effluvii 
4155 6.35E-01 0.050 Collinsella aerofaciens 
4515 1.83E-08 0.516 Lachnospiraceae 
744 1.63E-04 0.345 Tyzzerella 
783 8.92E-02 0.155 t__[Eubacterium rectale] ATCC 33656 
1486 1.42E-02 0.230 Sporobacter 
1741 7.29E-01 0.037 t__[Eubacterium rectale] ATCC 33656 
1958 3.13E-07 0.470 Faecalibacterium 
224 7.53E-08 0.499 t__Prevotella copri DSM 18205 
2441 4.20E-08 0.509 t__Prevotella copri DSM 18205 
2497 3.13E-07 0.470 t__Prevotella copri DSM 18205 
2542 1.69E-12 0.653 t__Prevotella copri DSM 18205 
2543 3.33E-11 0.615 t__Prevotella copri DSM 18205 
2628 1.34E-07 0.490 t__Prevotella copri DSM 18205 
2656 4.40E-09 0.547 t__Prevotella copri DSM 18205 
3307 2.16E-09 0.557 t__Prevotella copri DSM 18205 
3631 2.05E-05 0.393 [Eubacterium] hallii 
3790 7.85E-04 0.307 t__Blautia obeum ATCC 29174 
3897 6.29E-05 0.374 Blautia 
3905 2.01E-02 0.220 Blautia 
4107 7.85E-04 0.307 Collinsella aerofaciens 
4148 2.01E-02 0.220 Collinsella aerofaciens 
423 8.18E-01 -0.031 t__Bacteroides stercoris ATCC 43183 
4324 5.16E-04 0.316 t__Roseburia inulinivorans DSM 16841 
4337 4.75E-04 0.326 Anaerosporobacter 
772 1.42E-02 0.230 Lachnoclostridium 
857 2.90E-04 0.335 Clostridiales 
984 1.98E-06 0.441 Prevotella copri 
985 7.00E-06 0.413 Prevotella 
 
Table 4.4. OTU prevalences in HmongThai and Hmong1st. Related to Figure 2. 
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P1 Prevotella_stercorea_DSM_18206_Scfld0 
P2 Prevotella_copri_strain_Indica_contig00001 
P3 Prevotella_copri_DSM_18205_Scfld26 
P4 Prevotellamassilia_timonensis_strain_Marseille-P2831 
B1 Bacteroides_vulgatus.1cell.HGAP3_contig1 
B2 Bacteroides_stercoris_ATCC_43183_Scfld_02_16 
B3 Bacteroides_finegoldii_DSM_17565_Scfld32 
B4 Bacteroides_uniformis_str._3978_T3_i_gbf3978T3i.contig.0 
B5 Bacteroides_massiliensis_B84634_=_Timone_84634_=_DSM_17679_=_J
CM_13223_strain_DSM_17679_aczJl-supercont1.1 
B6 Bacteroides_dorei_CL02T12C06_supercont1.1 
B7 Bacteroides_caccae_CL03T12C61_supercont1.1 
B8 Bacteroides_caccae_strain_2789STDY5834946 
B9 Bacteroides_intestinalis_DSM_17393_B_intestinalis-2.0.1_Cont607 
 
Table 4.5. NCBI Genome IDs of Bacteroides and Prevotella strains. Related to 
Figure 3. 
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Food Item q-value p-value r 
 Cooked cereals rice 7.29e-315 2.52e-316 -0.96 
 Fruits excluding berries 3.12e-28 2.15e-29 0.45 
 Milk fluid 2.82e-12 2.91e-13 0.30 
 Coffee 2.58e-07 3.71e-08 0.23 
 Other vegetables cooked 2.58e-07 4.45e-08 -0.23 
 White breads rolls 7.71e-07 1.60e-07 0.22 
 Mixtures mainly grain pasta or bread 2.15e-06 5.18e-07 0.21 
 Finfish 2.80e-06 7.72e-07 -0.21 
 Soft drinks carbonated 3.60e-05 1.12e-05 0.19 
 Other vegetables raw 7.46e-05 2.57e-05 -0.18 
 Citrus fruits 8.43e-05 3.20e-05 0.18 
 Frankfurters sausages lunchmeats meat spreads 8.70e-05 3.60e-05 0.18 
 Carrots 2.40e-04 1.07e-04 0.16 
 Chicken 1.14e-03 5.51e-04 0.15 
 Beef roasts stew meat corned beef beef brisket 
sandwich steaks 
1.86e-03 9.61e-04 0.14 
 Fruit juices excluding citrus 2.18e-03 1.21e-03 0.14 
 Cookies 2.18e-03 1.28e-03 0.14 
 
Table 4.6. Foods (summarized at level 3) that are significantly correlated with PC1 
of the diet-based unweighted Unifrac PCOA (q < 0.01). Related to Figure 4. 
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Figure 2.1. Disease model of host-microbiome development.  
Disease classes are associated with cascading dysbiosis types, with important dependencies on host-
microbiome development. Note that disease classes and dysbiosis types are not necessarily mutually 
exclusive. The proposed mechanisms presented are supported by extensive evidence in the literature, both 
from mechanistic studies and from epidemiological surveys. Due to the very large number of references, 
the citations represented in this figure can be found in Table 2.1. 
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Figure 2.2. Trajectories for infant recovery after antibiotic exposure.  
(A) Infant gut microbiomes develop rapidly and experience large changes during infancy before becoming 
indistinguishable from adult microbiomes by age 2. Dysbiosis in infants can displace (no recovery) or delay 
(slow recovery) development on the normal growth trajectory. (B) Samples were obtained from a single 
infant over time (Koenig et al., 2011), and microbiome distance (Bray-Curtis) to self at 2 years old was 
plotted over time. Fecal samples collected immediately after antibiotics are denoted in blue. A smoothing 
spline (in light blue) reveals a noticeable change in trajectory of development after use of antibiotics, 
mirroring the deviation in trajectory predicted in (A). 
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Figure 2.3. Percent decrease in gut microbiome biodiversity across studies with 
different antibiotic exposures.  
All fecal samples were collected 1 week after antibiotic course was completed, except where noted by 
subscripts. The Dethlefsen 2011 study included three subjects (A, B, C) who received two courses 6 
months apart. DSample taken during antibiotic treatment; 4Sample taken 4 weeks after antibiotic 
completion; 8Sample taken 8 weeks after antibiotic completion (Dethlefsen and Relman, 2011; Dethlefsen 
et al., 2008; Fouhy et al., 2012; Robinson and Young, 2010; Russell et al., 2012; Tanaka et al., 2009). 
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Figure 2.4. Predicted Microbiome Maturity Index (MMI).  
The predictive MMI for a given child is compared to the true age of that child. The MMI was predicting 
using random forests regression algorithm trained on the microbiome compositions and true ages of all 
children except for one being predicted. True age was predicted to within ± 1.3 months (standard deviation 
of the predicted error), demonstrating the feasibility of modeling the maturation of the gut microbiota as a 
predictable process across individuals. Microbiome samples were obtained from children living in the USA 
(Yatsunenko et al., 2012). 
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Figure 3.1. Workflow of data and website generation. 
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Figure 3.2. Website screenshots of MLRepo homepage, task, and dataset pages. 
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Figure 3.3. ROCs comparing random forest and SVM with different kernels. 
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1 bacteremia vs no bacteremia 11 white vs black, vaginal 21 stool vs tongue
2 high fat vs low fat diet 12 black vs hispanic, vaginal 22 subgingival vs supragingival plaque
3 chlortetracycline vs control, cecal 13 low vs high nugent category 23 healthy vs tumor biopsy, paired
4 chlortetracycline vs control, fecal 14 healthy vs cd, stool 24 lean vs obese, mz/dz/mom
5 penicillin vs vancomycin, cecal 15 healthy vs uc, stool 25 normal vs diabetes glucose tolerance
6 penicillin vs vancomycin, fecal 16 malawi vs venezuela, adults only 26 impaired vs diabetes glucose tolerance
7 elderly vs young 17 male vs female, usa 27 healthy vs type 2 diabetes
8 control vs cd, ileum 18 us vs malawi, adults only 28 healthy vs cirrhosis
9 control vs cd, rectum 19 animal vs plant diet, last diet day
10 male vs female, stool 20 gastrointestinal vs oral
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Figure 3.4. ROCs comparing NCBI RefSeq and Greengenes 97 databases. 
  
1 bacteremia vs no bacteremia 13 low vs high nugent category
2 high fat vs low fat diet 14 healthy vs cd, stool
3 chlortetracycline vs control, cecal 15 healthy vs uc, stool
4 chlortetracycline vs control, fecal 16 malawi vs venezuela, adults only
5 penicillin vs vancomycin, cecal 17 male vs female, usa
6 penicillin vs vancomycin, fecal 18 us vs malawi, adults only
7 elderly vs young 19 animal vs plant diet, last diet day
8 control vs cd, ileum 20 gastrointestinal vs oral
9 control vs cd, rectum 21 stool vs tongue
10 male vs female, stool 22 subgingival vs supragingival plaque 
11 white vs black, vaginal 23 healthy vs tumor biopsy, paired
12 black vs hispanic, vaginal 24 lean vs obese, mz/dz/mom 
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Figure 3.5. Summary statistics of framework and database comparisons.  
(A) AUCs presented as ratio of RF AUC to SVM AUC. (B) AUCs presented as ratio of RefSeq database 
AUC to Greengenes database AUC. 
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Figure 4.1. Assembly of a multi-generational Asian American cohort, while 
accounting for BMI and diet 
(A) Experimental design for cross-sectional and longitudinal cohorts. (B) Ratios of overweight-to-obese 
individuals across sample groups and over time in the U.S., separated by ethnicity due to differences in 
time in years. Sample sizes are not evenly distributed across time in the U.S. (C) Hmong in Thailand (n = 
43) and second-generation Hmong (n = 41) (ages 20-40) diet diversity, as seen across tree-based food 
items. Bars denote unique foods, with prevalence of foods reported averaged within HmongThai or 
Hmong2nd and displayed as a gradient. Items highlighted in red denote the most prevalent vegetables, 
sweets and beverages, grains, and meats reported within sample groups. Full descriptions of highlighted 
foods: Coffee, brewed, regular; Carbonated citrus fruit drink; Chinese cabbage or Bok Choy family, raw; 
Rice, white, no salt or fat added; Pork chop, broiled, baked, or grilled, lean only eaten; Chicken breast, 
roasted, skin not eaten. 
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Figure 4.2. Loss of diversity and native bacterial taxa with time in the U.S.  
(A) PCoA (unweighted UniFrac) of gut bacterial communities reveals that phylogenetic variation is 
strongly explained by sample group (ANOSIM R=0.25, P=0.001). 95% standard error ellipses are shown 
around HmongThai, KarenThai, Hmong2nd, and Controls. (B) Alpha diversity of obese and lean 
individuals across sample groups, in Shannon’s Diversity index and Faith’s Phylogenetic Distance (PD). P-
values denote significantly different groups using pairwise tests of sample groups with pooled BMI classes 
(Tukey’s HSD, α = 0.05). Using a two-way ANOVA analysis with BMI class and sample group as 
covariates, we found that obesity is significantly lower across all groups (P = 0.0044). (C) Prevalence of 
operational taxonomic units (OTUs) in HmongThai and Hmong1st, sorted by prevalence in HmongThai 
and by richness within sample group. OTUs shown are found in > 75% of HmongThai samples (See Table 
4.4). 
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Figure 4.3. Bacteroides and Prevotella strain diversity and abundances 
(A) Ratio of Bacteroides to Prevotella relative abundances, log transformed (B/P). Significant contributions 
from covariates that define the sample groups classes: Resident.Continent, P=3.4e−13; Birth.Continent, 
P=0.00085; Ethnicity, P=5.5e−12 (unbalanced two-way ANOVA). (KT=KarenThai; HT=HmongThai; 
K1=Karen1st; H1=Hmong1st; H2=Hmong2nd; C=Controls). (B) Bacteroides and Prevotella strain 
diversity in 44 samples across HmongThai, Hmong1st (who have lived in the U.S. for more than 30 years), 
and Controls. Strains were selected if coverage > 50% in at least one sample. Hierarchical clustering of 
strains and samples within group is based on relative abundances and coverage < 1% of a strain within 
person is considered not present (not plotted). See Table 4.5 for strain names. (C) CAZymes with 
significantly different relative abundances among HmongThai, Hmong1st (who have lived in the U.S. for 
more than 30 years), and Controls (Mann Whitney U test, FDR-corrected q < 0.05).  
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Figure 4.4. Dietary acculturation is detectable using novel food tree and partially 
explains microbiome variation 
(A) Comparison of macronutrients consumption levels across sample groups. Ethnicity is significantly 
associated with calories (P=3.4e−05), sugars (P=0.00023), fat (P=1.3e−07), protein (P=3.2e−07), whereas 
current continent of residency is associated with sugar (P=1.3e−16), fat (P=7.1e−24), and protein 
consumption (P=5.7e−05), and birth continent is only associated with Fat consumption (P=0.0081) 
(unbalanced two-way ANOVA). (HT=HmongThai; KT=KarenThai; H1=Hmong1st; K1=Karen1st; 
H2=Hmong2nd; C=Controls). (B) PCoA of unweighted UniFrac diet-based distances reveal significant 
clustering by sample group (ANOSIM R=0.29, P=0.001), with Hmong2nd now clustering with Hmong1st 
instead of with Controls as reported with microbiome-based distances. Dietary acculturation can be seen 
along PC1, as it is significantly correlated with years spent in the U.S. (ρ=0.56, P=2.2e-16). (C) 
Redundancy analysis (RDA) of the unweighted Unifrac microbiome-distances constrained by the first 5 
principal coordinates of the PCoA of unweighted Unifrac food-distances. The resulting RDA explains 
16.8% of the total variation explained by PC1 and PC2 of the microbiome PCoA (Figure 4A). 
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Figure 4.5. Gut biodiversity decreases with time spent in the U.S. 
(A) Unweighted Unifrac PCoA of gut microbiomes of first-generation Hmong and Karen participants (N = 
281), colored by years spent in the U.S. which ranges from 1 day to 40.6 years. PC1 is strongly correlated 
with the amount of time spent in the U.S. (⍴ = 0.62, p < 2.2e-16). (B) Unweighted Unifrac PCoA of gut 
microbiomes of cross-sectional participants (N=550), colored by Faith’s Phylogenetic Diversity. PC1 is 
negatively correlated with phylogenetic richness (⍴ = -0.34, p < 3.19e-09). (C) In first-generation Hmong, 
diversity significantly decreases over time in the U.S. (multiple regression: Years in US β = -0.18, P = 
0.0275; BMI β = -0.05, P = 0.81), but a significant association is not observed in first-generation Karen 
(Years in US β = -0.17, P = 0.71; BMI β = -0.27, P = 0.28). Interaction terms were not significantly 
associated with diversity, and were removed from the model. 
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Figure 4.6. Prevotella displacement is observable within one decade in the U.S. 
(A) Similarity (1 / Aitchison's distance) of microbiomes relative to Thai-based groups and to Controls. (B) 
Log ratio of Bacteroides to Prevotella of first-generation groups are significantly correlated to years spent 
in the U.S. (ρ = 0.44, P = 8.76e-15). Significantly correlated trends persist after stratification by ethnicity 
(Hmong ρ = 0.47, P = 8.16e-19; Karen ρ = 0.19, P = 0.023). (HT=HmongThai; KT=KarenThai; 
H2=Hmong2nd; C=Controls; 0-40=Years spent in the U.S. by Hmong1st and Karen1st). 
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Figure 4.7. Longitudinal changes immediately pre- and post-arrival to the U.S. 
(A) Comparison of per-participant changes between first and last months of the study in BMI, (B) protein 
consumption, (C) dietary diversity (Faith’s PD), and (D) Bacteroides to Prevotella ratios (paired t-test, 
macronutrients adjusted for multiple comparisons using false discovery rate, q < 0.05). (E) Bacteroides and 
Prevotella strain profiles are mostly stable after 6 months. Samples (columns) from the same participant are 
denoted by color, and M1 and M6 correspond to Month 1 Sample and Month 6 Sample, respectively. 
Selected strains are identical to Figure 4B (at least 50% coverage per sample across N=55 samples, see 
Table 4.5). (F) Taxonomic area charts of relative abundances of dominant genera (other taxa not shown) in 
6 individuals who began the longitudinal study while in a refugee camp in Thailand. First available samples 
were collected 6 to 34 days before departure, and second samples were collected 1 to 6 days after arrival to 
the U.S.  
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Figure 4.8. Western diet and Western microbiome induce deleterious responses in 
humanized mice 
(A) Mouse experimental study design included Thai- (T) or U.S.-based (U) donors and high-fiber (H) or 
low-fiber (L) diet, resulting in four groups: TH=Thai-HighFiber; UH=US-HighFiber; TL=Thai-LowFiber; 
UL=US-LowFiber. (B) PCoA using unweighted Unifrac distances of mouse microbiomes at study 
endpoints (8 or 10 weeks). (C)-(E) Feed efficiency, percent fat, fasting blood glucose were compared 
between groups at the end of 8 weeks (two-way ANOVA). (F) Immune cell counts (cell population counts 
are normalized by counts of live CD45+ cells) in the small intestine intraepithelial lymphocytes (two-way 
ANOVA). 
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Chapter 4 Supplemental Figures 
 
 
Figure 4.S1. Geographical locations of recruitment sites in Thailand. Related to 
Figure 4.1. 
Khun Chang Khian in Chiang Mai province and Mae La camp in Tak Province. 
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Figure S1. Geographical locations of recruitment sites in Thailand. Related to 
Figure 1.
Khun Chang Khian in Chiang Mai province and Mae La camp in Tak Province.
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Figure 4.S2. Alpha diversity boxplots of obese and lean individuals, separated by 
ethnicity. Related to Figure 4.4. 
Post-hoc analysis with Tukey’s HSD test across sample groups. 
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Figure S2. Alpha diversity boxplots of obese and lean individuals, separated by 
ethnicity. Related to Figure 2.
Post-hoc analysis with Tukey’s HSD test across sample groups.
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Figure 4.S3. Functional annotations. Related to Figure 4.4. 
(A) Differentiated relative abundances of functional pathways between HmongThai and Hmong1st (asin-
sqrt transformed abundances, ANOVA, FDR-corrected q < 0.10). (B) Prevalence of predicted biosynthetic 
gene clusters within sample groups. Comparison of groups with a looped Fisher’s exact test reveals that a 
predicted bacteriocin cluster is enriched in Hmong1st relative to HmongThai (P = 0.0002, FDR-corrected q 
< 0.10). 
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PWY−7219: adenosine ribonucleotides de novo biosynthesis
PWY−7456: mannan degradation
PWY−5659: GDP−mannose biosynthesis
PWY−6284: superpathway of unsaturated fatty acids biosynthesis (E. coli)
PWY−5971: palmitate biosynthesis II (bacteria and plants)
PWY−6113: superpathway of mycolate biosynthesis
PWY−5973: cis−vaccenate biosynthesis
PWY−5989: stearate biosynthesis II (bacteria and plants)
TRNA−CHARGING−PWY: tRNA charging
CALVIN−PWY: Calvin−Benson−Bassham cycle
FASYN−ELONG−PWY: fatty acid elongation −− saturated
PWYG−321: mycolate biosynthesis
PYRIDNUCSYN−PWY: NAD biosynthesis I (from aspartate)
PWY−6897: thiamin salvage II
PWY−6700: queuosine biosynthesis
THISYN−PWY: superpathway of thiamin diphosphate biosynthesis I
PWY−3481: superpathway of L−phenylalanine and L−tyrosine biosynthesis
COLANSYN−PWY: colanic acid building blocks biosynthesis
PWY−6969: TCA cycle V (2−oxoglutarate:ferredoxin oxidoreductase)
PWY0−1479: tRNA processing
PHOSLIPSYN−PWY: superpathway of phospholipid biosynthesis I (bacteria)
PWY−1269: CMP−3−deoxy−D−manno−octulosonate biosynthesis I
PWY−7200: superpathway of pyrimidine deoxyribonucleoside salvage
PWY−6435: 4−hydroxybenzoate biosynthesis V
GLUCONEO−PWY: gluconeogenesis I
PWY−7323: superpathway of GDP−mannose−derived O−antigen building blocks biosynthesis
PWY−6731: starch degradation III
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PWY−2201: folate transformations I
ORNDEG−PWY: superpathway of ornithine degradation
PWY−3781: aerobic respiration I (cytochrome c)
PWY−6608: guanosine nucleotides degradation III
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PWY−6562: norspermidine biosynthesis
PPGPPMET−PWY: ppGpp biosynthesis
PWY−7560: methylerythritol phosphate pathway II
UNMAPPED
PANTOSYN−PWY: pantothenate and coenzyme A biosynthesis I
COA−PWY−1: coenzyme A biosynthesis II (mammalian)
COBALSYN−PWY: adenosylcobalamin salvage from cobinamide I
THISYNARA−PWY: superpathway of thiamin diphosphate biosynthesis III (eukaryotes)
SER−GLYSYN−PWY: superpathway of L−serine and glycine biosynthesis I
PWY−6609: adenine and adenosine salvage III
P221−PWY: octane oxidation
PWY66−389: phytol degradation
PWY−6876: isopropanol biosynthesis
PWY−7013: L−1,2−propanediol degradation
PWY−841: superpathway of purine nucleotides de novo biosynthesis I
PWY−7228: superpathway of guanosine nucleotides de novo biosynthesis I
PWY0−166: superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
P461−PWY: hexitol fermentation to lactate, formate, ethanol and acetate
PWY−241: C4 photosynthetic carbon assimilation cycle, NADP−ME type
FERMENTATION−PWY: mixed acid fermentation
PWY−6549: L−glutamine biosynthesis III
PWY−7115: C4 photosynthetic carbon assimilation cycle, NAD−ME type
PWY−5384: sucrose degradation IV (sucrose phosphorylase)
PWY−2941: L−lysine biosynthesis II
PWY−6309: L−tryptophan degradation XI (mammalian, via kynurenine)
P124−PWY: Bifidobacterium shunt
PWY−5188: tetrapyrrole biosynthesis I (from glutamate)
PWY0−1061: superpathway of L−alanine biosynthesis
P122−PWY: heterolactic fermentation
PWY−6901: superpathway of glucose and xylose degradation
PWY−7234: inosine−5'−phosphate biosynthesis III
PRPP−PWY: superpathway of histidine, purine, and pyrimidine biosynthesis
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PWY−6383: mono−trans, poly−cis decaprenyl phosphate biosynthesis
SALVADEHYPOX−PWY: adenosine nucleotides degradation II
PWY−7003: glycerol degradation to butanol
ARGSYNBSUB−PWY: L−arginine biosynthesis II (acetyl cycle)
P185−PWY: formaldehyde assimilation III (dihydroxyacetone cycle)
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PWY−5100: pyruvate fermentation to acetate and lactate II
PWY−5505: L−glutamate and L−glutamine biosynthesis
BIOTIN−BIOSYNTHESIS−PWY: biotin biosynthesis I
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PWY−7400: L−arginine biosynthesis IV (archaebacteria)
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PWY−7229: superpathway of adenosine nucleotides de novo biosynthesis I
GLYCOLYSIS: glycolysis I (from glucose 6−phosphate)
PENTOSE−P−PWY: pentose phosphate pathway
UNINTEGRATED
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ANAGLYCOLYSIS−PWY: glycolysis III (from glucose)
PWY0−845: superpathway of pyridoxal 5'−phosphate biosynthesis and salvage
HISDEG−PWY: L−histidine degradation I
P108−PWY: pyruvate fermentation to propanoate I
PWY−6121: 5−aminoimidazole ribonucleotide biosynthesis I
PWY−6122: 5−aminoimidazole ribonucleotide biosynthesis II
HISTSYN−PWY: L−histidine biosynthesis
PWY−3841: folate transformations II
TRPSYN−PWY: L−tryptophan biosynthesis
PWY−6385: peptidoglycan biosynthesis III (mycobacteria)
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Figure 4.S4. Macronutrient pairwise comparisons. Related to Figure 4.4. 
Pairwise comparisons with Tukeys’ HSD, significant p-values < 0.05 are shown. 
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Figure S4. Macronutrient pairwise comparisons. Related to Figure 4.
Pairwise comparisons with Tukeys’ HSD, significant p-values < 0.05 are shown.
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Figure 4.S5. Bipartite network of participant dietary records and food items. 
Related to Figure 4.4. 
(A) Edges and participants are colored by sample group, and food items are shown as white-filled 
diamonds. (B) We highlight the high prevalence of rice consumption. Participants who consumed rice are 
denoted as yellow nodes and yellow edges connected to the centroid (rice), otherwise participants were 
colored by sample group. 
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Figure S5. Biparti e network of participant dietary records and food items. Related 
to Figure 4.
(A) Edges and particip nts are colored by sample gr up, and food items are shown as 
white-filled diamonds. 
(B) We highlight the high prevalence f ri e consumption. Participants who consumed ice 
are denoted as yellow nodes and yellow edges connected to the centroid (rice), otherwise 
participants were colored by sample group.
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Figure 4.S6. Procrustes of diet and microbiome distances. Related to Figure 4.4. 
(A) Procrustes permutation shows significant relatedness between individuals’ food and microbiome 
profiles. Shown at left is the Procrustes PCoA for a representative permutation (median Procrustes sum of 
squares distance from 9 permutations) compared to the original data Procrustes PCoA, and at right are the 
individual multidimensional distances between each individuals’ food and microbiome data after rotation. 
These points are significantly closer than expected by random chance (p = 1e-10, Mann Whitney U test). 
(B) All nine permutations of the Procrustes from panel A, including boxplots for the individual food-
microbiome distances; p-values are generated from the protest() function in package “vegan” in R. 
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Figure S6. Procrustes of diet and microbiome distances. Related to Figure 4.
(A) Procrustes permutation shows significant relatedness between individuals’ food and 
microbiome profiles. Shown at left is th  Procrustes PCoA for a r present tive permutation 
(median Procruste  sum of squar s distance from 9 permut tions) compared to the 
original dat  Procrustes PCoA, and at right are the individual multidimensional distances 
between each individuals’ food and microbiome data after rotation. These points are 
significantly closer than expected by random chance (p = 1e-10, Mann Whitney U test).
(B) All nine permutations of the Procrustes from panel A, including boxplots for the 
individual food-microbiome distances; p-values are generated from the protest() function in 
package “vegan” in R.
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Figure 4.S7. PCoA of unweighted Unifrac distances of longitudinal samples. Related 
to Figure 4.7. 
First and last month samples are highlighted and connected by participant, with all intermediate monthly 
samples in gray. Inset shows the within-individual changes along PC1 and PC2 from first to last months 
(one sample t-test with change in PC1 or PC2). 
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Figure S7. PCoA of unweighted Unifrac distances of longitudinal 
samples. Related to Figure 7.
First and last month samples are highlighted and connected by participant, 
with all intermediate monthly samples in gray. Inset shows the within-individual 
changes along PC1 and PC2 from first to last months (one sample t-test with 
change in PC1 or PC2).
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Appendix 
Appendix A. Survey form. 
1. What is your birthdate? _____________ 
2. Do you live in public housing? _______ 
3. Do you receive medical assistance? _______ 
4. Do you have any children?  _______ 
If yes, do they qualify for free lunch? ______ 
 
5. How many years have you gone to school?  
_____  English as a Second Language 
_____  Less than High School 
_____ High School 
_____  College  
_____  Graduate School 
 
6. What is your ethnicity? 
  ____ Hmong 
 ____ Karen 
  ____ Other: ______________________ 
 
7. What is your religion? 
  ____ Buddhism 
  ____ Christianity 
  ____ Hmong animism 
  ____ Islam  
  ____ Other: ______________________ 
  ____ None  
 
8. Where were you born?  Please write name: camp/village/city, province, country 
__________________________________________________________________ 
 
9. What type of place was that?  
_____  a. Refugee camp.  
_____ b. Rural village.  
_____ c. Urban dwelling.  
_____  d. Other. _____________________ 
 
10. When did you arrive in the US? ______________________ 
 
11. Where did you live just before you arrived in the US? 
Please write name: camp/village/city, province, country 
__________________________________________________________________ 
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12. What type of place was this place?  
_____  a. Refugee camp.  
_____ b. Rural village.  
_____ c. Urban dwelling.  
_____  d. Other. _____________________ 
 
13. How long did you live there? ______________________ 
 
14. In this location, what did you usually eat per day? 
 
 Food and Drink Serving Size 
Breakfast   
 
 
 
 
 
Snack  
 
 
 
Lunch   
 
 
 
 
 
 
 
Snack  
 
 
 
Dinner   
 
 
 
 
 
 
 
Snack  
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15. What did you eat yesterday (including overnight)? 
 Food and Drink Serving Size 
Breakfast   
 
 
 
 
 
Snack  
 
 
 
Lunch   
 
 
 
 
 
 
 
Snack  
 
 
 
Dinner   
 
 
 
 
 
 
Snack  
 
 
 
 
16. Do you use tobacco - whether smoked cigarettes/cigars/pipes, or chewed tobacco? 
a. Never 
b. Currently- ever day use 
c. Currently- occasional use 
d. Used to use, now quit. 
 
17. Do you consume alcohol - whether beer, wine, whiskey or other liquors?  
a. Never 
b. Currently – 1-3 drinks every day 
c. Currently - 1-3 drinks every week 
d. Currently - 1-3 drinks every month 
e. Currently - 1-3 drinks occasionally (less than once a month) 
f. Used to drink, now quit. 
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Health Metrics 
 
18. Height 
________feet _____ inches 
 
19. Weight 
________ lb 
 
20. Waist Circumference 
________ inches 
 
21. Are you taking any medications? ______(Yes/No) 
If yes, please list: _____________________________ 
 
22. Do you know if you were breastfed as a child? 
If yes, do you know for how long? 
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Appendix B. Fecal sampling instructions 
How to Get Stool Sample 
 
Do this 1-4 days before you are going to bring us the sample.  
Urinate (pee) in the toilet before starting. 
 
For a video demonstration, please watch: 
http://z.umn.edu/impenglish 
 
The kit has these things:  
1.     A FecesCatcher paper 
2.     A tube  
3.     A stick 
4.     Latex-free gloves  
5.     A small envelope 
6.     A bag 
7.   A paper towel 
 
This is what you have to do: 
1. Gently open the FecesCatcher paper. Put the sticky ends on the left and right sides of 
the toilet. Make sure the center of the paper does not touch the water. Press hard on 
the sticky ends so they stick to the toilet.  
2. Have your normal bowel movement onto the paper. Make sure that nothing touches 
your stool, like toilet paper, water or urine. 
3. Wash and dry your hands. Put on the gloves. 
4. Unscrew the cap on the tube. Do not spill the liquid. Put the lid on the counter, with 
the inside facing up, towards the ceiling.  
5. Open the package with the stick. 
6. Get a small amount of stool on the stick, about the size of 3-4 grains of rice. 
7. Scrape the stool into the tube. 
8. Repeat this again to put another small amount of stool into the tube. 
9. Use the stick to evenly mix the stool and liquid in the tube. Throw away the stick. 
10. Tightly screw the lid on the tube. 
11. Place the tube in the small envelope and seal it. Place the envelope in the bag with the 
paper towel. 
12. Remove the FecesCatcher paper from the sides of the toilet.  Shake the FecesCatcher 
paper so the stool falls into the toilet.  
13. Either put the paper in a waste basket (recommended for all toilets, especially at 
home) Or: Put the paper into the toilet water, let it soak for 1-2 minutes and flush it 
down the toilet. 
14. Remove the gloves and put into the trash. Wash your hands. 
15. Keep the fecal sample at room temperature and away from children until you 
can return it to us.  
